Using Simian Virus 40 As A Model To Determine The Effects Of Replication And Transcription On Histone Methylation by Kallestad, Les
University of North Dakota
UND Scholarly Commons
Theses and Dissertations Theses, Dissertations, and Senior Projects
January 2016
Using Simian Virus 40 As A Model To Determine
The Effects Of Replication And Transcription On
Histone Methylation
Les Kallestad
Follow this and additional works at: https://commons.und.edu/theses
This Dissertation is brought to you for free and open access by the Theses, Dissertations, and Senior Projects at UND Scholarly Commons. It has been
accepted for inclusion in Theses and Dissertations by an authorized administrator of UND Scholarly Commons. For more information, please contact
zeineb.yousif@library.und.edu.
Recommended Citation
Kallestad, Les, "Using Simian Virus 40 As A Model To Determine The Effects Of Replication And Transcription On Histone














USING SIMIAN VIRUS 40 AS A MODEL TO DETERMINE THE EFFECTS OF 













Submitted to the Graduate Faculty 
of the 
University of North Dakota 
 
in partial fulfillment of the requirements 
 
for the degree of 
 
Doctor of Philosophy 
 















This dissertation submitted by Les Kallestad in partial fulfillment 
of the requirements for the Degree of Doctor of Philosophy from the 
University of North Dakota, has been read by the Faculty Advisory 






    ____________________________ 
    Barry Milavetz 
 
    ____________________________ 
    Joyce Ohm 
 
    ____________________________ 
    Min Wu 
 
    ____________________________ 
    Ann Flower 
 
    ____________________________ 






This thesis or dissertation is being submitted by the appointed advisory committee 
as having met all of the requirements of the School of Graduate Studies at the University 















Title  Using Simian Virus 40 As A Model To Determine The Effects Of 
Replication And Transcription On Histone Methylation  
 
Department Biochemistry and Molecular Biology   
 
Degree  Doctor of Philosophy 
 
 
In presenting this dissertation in partial fulfillment of the requirements for a 
graduate degree from the University of North Dakota, I agree that the library of this 
University shall make it freely available for inspection. I further agree that permission for 
extensive copying for scholarly purposes may be granted by the professor who supervised 
my dissertation work or, in his absence, by the Chairperson of the department or the dean 
of the School of Graduate Studies. It is understood that any copying or publication or 
other use of this dissertation or part thereof for financial gain shall not be allowed without 
my written permission. It is also understood that due recognition shall be given to me and 
to the University of North Dakota in any scholarly use which may be made of any 
material in my dissertation.        
 
             _________________________ 
















TABLE OF CONTENTS 
 
LIST OF FIGURES ..................................................................................................................................... V 
LIST OF TABLES ..................................................................................................................................... VII 
ACKNOWLEDGMENTS ....................................................................................................................... VIII 
ABSTRACT ................................................................................................................................................ IX 
CHAPTER 
 
       i         INTRODUCTION ....................................................................................................................... 1 
 
       ii        STATEMENT OF THE PROBLEM ......................................................................................... 15 
 
       iii       MATERIALS AND METHODS .............................................................................................. 17 
 
       iv       SUMMARY OF RESULTS ...................................................................................................... 27 
 
       v        VIRION-MEDIATED TRANSFER OF SV40 EPIGENETIC INFORMATION ..................... 33 
 
       vi      TRANSCRIPTION AND REPLICATION RESULT IN DISTINCT EPIGENETIC  
                MARKS FOLLOWING REPRESSION OF EARLY GENE EXPRESSION............................ 52 
 
       vii     TRANSCRIPTIONAL REPRESSION IS EPIGENETICALLY MARKED  
                 BY H3K9 METHYLATION DURING SV40 REPLICATION ............................................... 73 
 
       viii    DISCUSSION AND CONCLUSIONS .................................................................................... 101 
 






LIST OF FIGURES 
Figure Page 
1. Methylated H3K4 (A) and H3K9 (B) are present in SV40 chromatin  
during a lytic infection. ..........................................................................................36 
 
2. Methylation of histone H3 affects infectivity and stability of infecting SV40 
chromatin. ..............................................................................................................45 
 
3. Time course of biological processes during SV40 lytic cycle ...............................56 
4. Repression of active early transcription does not result in an increase in 
H3K9me1. ..............................................................................................................62 
 
5. H3K9me2 is significantly increased during active early transcription  
in the site I deletion mutant cs1085. ......................................................................64 
 
6. Two copies of Site I directs the incorporation of more H3K9me1  
compared to one copy of Site I in SV40 minichromosomes  
isolated at 48 h post-infection but not at 8 h post-infection. ..................................66 
 
7. H3K4me1 and H3K9me1 are introduced into wild-type SV40  
minichromosomes primarily during active replication. .........................................68 
 
8. Inhibition of transcription with 5,6-dichloro-1-beta-D- 
ribofuranosylbenzimidizole (DRB) stimulates the incorporation  
of H3K9me2 and H3K9me3 into SV40 chromatin late in infection. ....................80 
 
9. The 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB)- stimulated 
introduction of H3K9me2 and H3K9me3 is partially dependent upon ongoing 
DNA Replication. ..................................................................................................82 
 
10. The 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB)- stimulated 





11. The 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB)- stimulated 
introduction of H3K9me2 and H3K9me3 is partially associated with 
minichromosomes containing RNAPII. .................................................................87 
 
12. The introduction of H3K9me2 and H3K9me3 is inhibited by sodium butyrate 
stimulation of transcription during active replication. ...........................................88 
 
13. The pool size of SV40 minichromosomes containing RNAPII is dynamic and 





LIST OF TABLES 
Table Page 
1. Writers and Erasers in Mammals .............................................................................5 
2. Co-localization of modified histones on SV40 minichromosomes .......................38 
3. Presence of modified histones in SV40 minichromosomes ...................................41 






 Firstly, I want to thank Barry Milavetz for being a great mentor and working with 
me during my time as a graduate student. I also want to thank Kathrin Sukalski for being 
a welcoming person to incoming students. I want to acknowledge my committee for 
assisting me and providing invaluable feedback. Lastly, I want to thank my parents for 
being supportive of me at all points in my life, without them I would not have been able 







Simian Virus 40 (SV40) is a well-characterized virus whose small circular DNA 
genome is organized into chromatin and, as a consequence, undergoes many of the same 
biological processes observed in cellular chromatin. SV40 early transcription is repressed 
when the product of early transcription, T-antigen, binds to its cognate regulatory 
sequence, Site I, in the promoter of the SV40 minichromosome.  We have subsequently 
shown that T-antigen binding to Site I results in the replication-dependent introduction of 
H3K9me1 into SV40 chromatin late in infection. Since H3K9me2 and H3K9me3 are also 
present late in infection, we determined whether their presence was also related to the 
status of ongoing transcription and replication. 
In order to determine the capacity of SV40 epigenetic regulation, we have 
analyzed SV40 chromatin from minichromosomes and virions for the presence of 
modified histones using various ChIP techniques and correlated these modifications with 
specific biological effects on the SV40 life cycle. Since repression is frequently 
epigenetically marked by the introduction of specific forms of methylated histone H3, we 
characterized the methylation of H3 tails during transcription and replication in wild-type 
SV40 minichromosomes and mutant minichromosomes which did not repress T-antigen 
expression. While repressed minichromosomes following replication were clearly marked 
with H3K9me1 and H3K4me1, minichromosomes repressed during early transcription 
were not similarly marked. Instead repression of early transcription was marked by a 
significant reduction in the level of H3K9me2. The replication dependent introduction of 
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H3K9me1 and H3K4me1 into wild-type SV40 minichromosomes was also observed 
when replication was inhibited with aphidicolin.  
We observed that H3K9me2/me3 was specifically introduced when transcription 
was inhibited during active replication. The introduction of H3K9me2/me3 that occurred 
when transcription was inhibited was partially blocked when replication was also 
inhibited. The introduction of H3K9me2/me3 did not require the presence of H3K9me1 
since similar results were obtained with the mutant cs1085 whose chromatin contains 
very little H3K9me1. 
Our results demonstrate that, like its cellular counterpart, SV40 chromatin is 
capable of passing biologically relevant transgenerational epigenetic information between 
infections. Our data suggest that methylation of H3K9 can occur either as a consequence 
of a specific repressive event such as T-antigen binding to Site I or as a result of a general 
repression of transcription in the presence of active replication. The results suggest that 
the nonproductive generation of transcription complexes as occurs following DRB 
treatment may be recognized by a 'proof reading' mechanism, which leads to the specific 










 All biological systems have blueprints which are used to construct mature living 
organisms, whether these be single cell bacteria or complex sentient multi-organ beings such as 
ourselves.  These blueprints are made up of a pair of 2 nm thick deoxyribonucleic acids strands 
(DNA), which are macromolecules built from nucleotides consisting of a base (guanine, adenine, 
thymine or cytosine), a sugar (deoxyribose), and a phosphate group.  These macromolecules can 
vary in size, with SV40 DNA consisting of 5,243 base pairs (BP) and human chromosome 
number 1 being about 220 million BP in length. 
 By a process referred to as transcription this double stranded DNA can be read by RNA 
polymerase II and an RNA molecule called messenger RNA (mRNA) is created which is 
complementary to the DNA sequence read except thymines are replaces with uridines.  This 
mRNA gets transported out of the nucleus, finds ribosomes, and forms proteins in a process 
referred to as translation.  These steps happen in a highly controlled manner, starting with DNA 
and ending up with protein products that make up the majority of an organism. 
 While bacteria and higher level organisms such as humans both use DNA as the form of 
nucleic acid in their blueprints, higher order organisms (eukaryotic cells) have an added obstacle 
of having large amounts of DNA that needs to be efficiently stored.  For example, each human 
cell contains about 2 meters of DNA that needs to be packaged into a cellular nucleus that is four 
to five microns in diameter.  Eukaryotic cells not only overcame this obstacle through the 
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condensation of DNA, but in the process added a highly complex mechanism to transcriptional 
control that we are beginning to more fully understand. 
 
Nucleosomes 
 The first unit of DNA condensation is the nucleosome.  A single nucleosome comprises 8 
proteins, two copies each of the histones H2A, H2B, H3, and H4.  Histone proteins are small 
basic proteins and have a globular domain containing about 75% of the protein's mass and a 
flexible amino terminus (referred to as the “histone tail” containing the remaining 25%). These 
proteins aggregate together to form a thick disk-like structure with 146 BP of DNA wrapped 
around to make a structure that is 11nm thick known as a nucleosome. In between nucleosomes 
there is a variable amount of linker DNA and another protein named H1 which binds DNA at the 
entry and exit site on the nucleosome, helps stabilize nucleosomes, and can promote higher order 
structure for these nucleosomes.(1) This genetic information is no longer naked DNA and is now 
coiled around nucleosomes, which is referred to as chromatin.  It is important to the cell no naked 
DNA  be present in healthy conditions, because naked DNA serves as one of the signals to cells 
that there is an abnormal condition like DNA damage or viral DNA present.  SV40, the model 
system used for the studies described in this dissertation has its genetic information in the basic 
nucleosome DNA form referred to as chromatin.  Eukaryotic organisms can further condense this 
chromatin by packing the nucleosomes into a tight 30nm fiber.  This 30 nm fiber can be 
connected to a scaffold and be further condensed and ultimately packaged into a tight structure 
called a chromosome.  These higher order chromatin structures play a role in regulating gene 







 Chromatin structure originally was thought to exist solely to ensure efficient packaging of 
cellular DNA.  However, this idea has subsequently changed based on studies on nucleosome 
positioning.  If packing was the sole function of chromatin nucleosomes would be expected to 
have a random position on chromatin.  Early experiments using endonuclease digestion showed 
that random nucleosome location was primarily the case for cellular chromatin.  However, there 
were also domains of chromatin which were free of nucleosomes known as nucleosome-free 
(NFR) regions.  The NFRs  are most often found in promoter regions or transcriptional start sites 
and can be formed in a variety of ways.  (2) Alternatively an NFR can be formed by a more 
dynamic mechanism in which chromatin remodeling complexes, such as SWI/SNF 
(SWItch/Sucrose NonFermentable-B) and RSC (Remodels the Structure of Chromatin), use ATP 
to either remove or slide nucleosomes. (3) It is now clear that nucleosomes and higher order 
chromatin structure not only efficiently packages DNA but also plays important developmental 
and regulatory roles. (4) 
 Heterochromatin is the term for condensed tightly packed DNA that is typically located 
at the periphery of the nucleus and comes in at least two forms, constitutive, which is always 
repressed and facultative, which can respond to signals and become transcriptionally active.  
Lightly packed chromatin is called euchromatin.  Euchromatin is the portion of the genome that is 
gene rich and is able to undergo active transcription.  Euchromatin also lacks the higher order 
chromatin structure and resembles beads on a string, with the individual nucleosomes being the 





 Histones can be post-translationally modified at over 60 amino acid residues.  These 
known modifications include methylation, acetylation, propionylation, butyrylation, formylation, 
phosophorylation, ubiquitylation, sumoylation, citrullination, proline isomerization, ADP 
ribosylation, and most recently discovered, crotonylation. (5) (Table 1) The studies presented 
here focus on methylation and acetylation, though other modifications also have biologically 
significant functions. 
 As previously mentioned, histones have amino terminal tails that protrude from the 
globular region of the nucleosome.  These tails are lysine and arginine rich and both of these two 
unmodified amino acids bear a positive charge. (6) The phosphate backbone of DNA contains a 
negative charge resulting in a strong interaction between DNA and histones, causing DNA to be 
tightly wound around the nucleosomes, creating an obstacle for proteins, namely transcription 
factors, to recognize and bind to their target DNA sequence.  Modification of the histone tails 
provide modulation of this interaction both by neutralization of these native charges and by acting 
as a signal that can be recognized by other proteins, resulting in a wide range of tightly regulated 
and specific outcomes. (7) 
 
Histone Methylation 
 Histones can be methylated on their lysine and arginine amino acid residues by a variety 
of lysine methyltransferases and can conversely be demethylated by lysine demethylases allowing 
for dynamic regulation mechanism.  Unmodified lysines have a side group bearing a positive 
charge.  Methylation of individual lysines can occur in three different forms, monomethylation, 
dimethylation, and trimethylation, all of which leave the negative charge intact. (8)  In contrast, 
arginine can undergo only monomethylation and dimethylation.  These modifications instead act 
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chromo, and PHD domains being the predominant ones. (9)Histone modifications can recruit 
proteins with a high degree of specificity, depending on which lysine is modified and what degree 
of methylation is present. (10)For example, H3K9 methylation can specifically recruit proteins 
with the chromo domain present on them, which generally result in hetrochromatin formation and 
cause a more stable and permanent gene silencing. H3K4 methylation is generally thought to be 
associated with transcriptional start sites and active gene transcription.  H3K27 methylation has 
been linked with transcriptional repression.  Interestingly, H3K4 methylation and H3K27 
methylation can be bivalently located on a nucleosome which can result in genes poised for 
transcription yet at the same time prevented from initiating transcription.  It is also important to 
note that these above stated general associations between histone lysine methylation and 
biological functions do not take into account that lysines can be mono-, di-, or tri-methylated, 
leading to a more complex regulatory network.  Some general types of methylation modification 
marks and their associated biological roles are outlined in atable 2. (11) 
 
Histone Acetylation 
Select lysines on histone's amino terminus tail can be acetylated.  Similarly to lysine 
methylation, lysine acetylation is a dynamic process of regulation with acetyl groups being added 
by histone acetyltranferases (HATs) and removed by histone deacetylases (HDACs).  The 
addition of an acetyl group to a lysine neutralizes the positive charge normally present on the 
amino acid, which in turn weakens the interaction between the nucleosome and DNA allowing 
the chromatin to be more loose in structure.  This is thought to allow the DNA to be more 
accessible to transcription factors and chromatin remodeling complexes. (12) 
 Acetylation of histone H3 is associated with activation of transcription and acetylation of 
histone H4 is associated with activation and also chromatin assembly. (11)Some models suggest 
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that HATs acetylate histones before RNA polymerase II,, with HDACs acting behind the RNA 
polymerase II, removing the acetylation after transcription, with the whole thing moving as a 
complex. (13)  Histone acetylation is enriched in the promoter region of actively transcribing 
genes and can function by recruiting proteins which contain a bromo domain.  Two examples of 
proteins recruited by their bromo domains to lysine acetylation are SWI/SNF (SWItch/Sucrose 
NonFermentable-B) and RSC (Remodels the Structure of Chromatin), which function to remove 
or slide histones away from the transcriptional start site prior to initiation of transcritpion. (14)  
There is also something referred to as global lysine acetylation which takes place at low levels 




 Individual histone modifications can at times be correlated to specific biological 
processes.  The histone code hypothesis states that histone modifications form specific patterns 
and these combinations of histone modifications confer a specific biological outcome.  In trying 
to understand the biological function of a potential histone code one major obstacle is the sheer 
number of potential modifications.  Taking histone H3 as an example, there are 280 million 
different lysine methylation patterns on its nineteen potential lysine residues, 4
19,
 and this does 
not take into account all the other types of histone modifications which are also possible.  With a 
nucleosome being made up of two copies each of H2A, H2B, H3, and H4 it is obvious that 
mapping all possible combinations would be very difficult if not impossible.  Instead, various 
laboratories have focused on select methylation and acetylation modifications in order to test the 
histone code hypothesis and determine the relationship between combinatorial histone 
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modifications and biological function.  The ones most studied were listed previously in the table 
of methylation and acetylation modifications. 
 
Simian Virus 40 
 Simian Virus 40 (SV40) is a small DNA tumor virus that was initially discovered in 1960 
as a contaminant in the polio vaccine as a result of using rhesus macaque cells which were 
contaminated with indigenous viruses. (15) The vaccine was licensed in 1955 in the United 
States.  The vaccine lots produced in 1961 or later were required to be free of SV40 but lots 
previously produced could still be used.  98 million United States residents received at least one 
dose of this vaccine from 1955-1961. (15) Not all lots contained SV40, and the formalin process 
used to produce the virus should have inactivated most or all of SV40, but it is impossible to 
determine the number of people who were actually infected with SV40 from the administration of 
this vaccine.  It is also known that people born after 1961 have become infected with SV40 so it 
appears that human to human transmission might be involved. (16) 
 In SV40's natural host, the rhesus macaque, the virus is typically a harmless passenger.  
After SV40's discovery it was injected into newborn rodents and discovered to be oncogenic.  It 
was also discovered to be able to transform rodent and human cells in culture.  This raised serious 
concerns over the possibility of increased cancer rates in humans who received the potentially 
contaminated vaccine produced prior to 1961. (15) The debate continues on today as to the role of 
SV40 in human cancer development although there is little evidence in support of a role.  
Nevertheless, as a result of this concern in the 1960s there was tremendous interest in 




Simian Virus 40 Structure 
SV40 has 5243 base pairs of DNA, making it one of the smaller known viruses.  It is 
encapsulated in 3 viral capsid proteins called VP1, VP2, and VP3 and is icosahedral in shape.  
Inside the protein coat the genetic information is stored with histones present on the DNA. (17)  
These histones can posses post-translational modifications, such as methylation and acetylation, 
that result from conditions of the previous infection, allowing for the potential of variable 
epigenetic information to be passed on to subsequent infections based on the environmental 
conditions of the previous infection. (18) 
 
Simian Virus 40 Chromosomes 
SV40 chromosomes are small, containing only 5243 base pairs of DNA, are circular, and 
are negatively coiled.  Two copies each of host cell produced histones H2A, H2B, H3, and H4 
come together and form nucleosomes which SV40 DNA wraps around. (21)  An SV40 
chromosome contains 24-26 nucleosomes with H1 not being found in virion particles but is found 
in intracellular chromosomes. (19) 
 
Simian Virus 40 Life-cycle 
 SV40 undergoes a number of distinct states during its life cycle in order to go from 
incoming infecting virions to newly created and released progeny virions.  The first of which 
occurs when SV40's VP1 comes into contact with carbohydrate moiety of the glycosphingolipid 
GM1 in the extracellular plasma membrane.  The interaction of VP1 and GM1, along with other 
cellular receptors, is quite complex, with at least 4 GM1 receptors required for stable binding to 
the membrane, along with substantial 3-dimensional rotation in the GM1 bound virion resulting 
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in 28 pentamers coming into contact with cellular receptors. (20)(21). Once inside the cell, the 
protein coat is partially removed and the chromosomes inside the virion are at least partially 
exposed. (22)  SV40's PKKKRKV nuclear localization signal (NLS) facilitates the transportation 
to the nucleus where it enters through the nuclear pore complex. (23) Within an hour of entering 
the nucleus early transcription begins, coding for T-antigen and small T-antigen (t-antigen).  
Initiation of late transcription begins at about 20 hours post infection and encodes for the viral 
capsid proteins VP1, VP2, and VP3.  Replication begins at 20-24 hours post-infection and newly 
replicated SV40 chromosomes can become encapsulated by the VP proteins and form virions.  
After about 72 hours post-infection these newly formed virions are transported to the cytoplasmic 
membrane and released from the cell. 
 If all of these steps happen as they should in a given cell type and the infection is 
productive and makes progeny virions the cell is said to be permissive.  However, if the incoming 
virions are unable to establish an infection the cell type is said to be non-permissive.  In non-
permissive infections the viral chromosome can become integrated into the hosts genome at a 
random location.  Gene products can then be produced, such as T-antigen, which in turn can 
result in a transformed cell and may result in cancer. 
 
SV40 Genome Organization 
 The SV40 genome can be divided into two categories based on their function, the coding 
region for proteins and the regulatory region.  The coding region can be further divided into two 
genetic units, the early coding region and the late coding region.  The early coding region is the 
part of the genome that becomes expressed at the beginning of an infection when the SV40 
chromosomes first get into the nucleus. The late coding region is expressed at very low levels 





around 20-24 hours post-infection.  The regulatory region consists of the promoters for both the 
early and late coding regions, SV40 enhancer, and the origin of replication. (24) 
Early Region 
 The early region of SV40 produces mRNA that codes for two proteins, T-antigen and t-
antigen.  This mRNA is transcribed from only one of the two strands of DNA, called the E (early) 
strand or – (minus) strand.  This strand is transcribed in a counterclockwise direction starting 
from the regulatory region.  Both T-antigen and t-antigen are transcribed from the same DNA 
sequence but due to differential splicing have different mRNAs that get translated, yielding two 
distinct gene products. (24) 
 
Large T Antigen 
 Large T Antigen (T-antigen) was first detected in 1977 as a 90-100 kDA polypeptide.  
Shortly thereafter it was determined that T-antigen was encoded by one of the three variations of 
the early SV40 mRNA.  T-antigen was found to bind DNA over a 120 bp region, centered around 
bp 67, which contains SV40's origin of replication, Site 1 which when bound by T-antigen down-
regulates early transcription, and Site 2 which when bound by T-antigen is involved in initiation 
of DNA replication. T-antigen has been shown to be able to function as a DNA helicase and when 
bound to single stranded DNA can bind and hydrolyze ATP, providing energy for the unwinding 
of DNA during replication. (25) 
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   Another function of T-antigen is to bind to retinoblastoma (Rb) and the tumor 
suppressor protein p53.  By binding Rb T-antigen overrides the G1 checkpoint and entry 
into S phase is permitted, allowing SV40 to replicate its DNA.  T-antigen also binds p53 
and inactivates some of  
its functions as a tumor suppressor. (26)  These interactions result in transformed cells 




The late proteins are transcribed from the L (late) strand or + (plus) strand of DNA in a 
clockwise direction starting from the regulatory region.  Two mRNAs are transcribed from the 
late region, each mRNA being translated into two protein products. One mRNA codes for VP2 
and VP3, while the other mRNA strand encode for VP1 and VP4.  VP1, VP2, and VP3 are capsid 
proteins, with VP4 being involved in disruption the cellular membrane.  VP1 and VP2 are 
thought to be the major structural components of the capsid, with VP3 proposed to be an 
intermediary between VP1/2 and the chromatin which needs to be packed inside. (24) VP1, VP2, 
and VP3 also possess a nuclear localization sequence directing their biological function. (27)  
Binding of VP1 is thought to prevent the function of histone deacetylates (HDACs) on the 
attached chromosome while still allowing histone acetyltransferases (HATs) to acetylate the 
chromosome, resulting in increased levels of histone actylation in virion particles compared to the 
pool of chromosomes at late times in infection when encapsulation is occuring. 
 
Simian Virus 40 Regulatory Region 
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 SV40's regulatory region spans about 420 bps (nt 5171-346) and contains the origin of 
replication, the enhancer, and both the early and late promoters.  The regulatory region contains 
many of the elements required for the control and regulation of transcription and replication and 
is located between the early and late regions of the genome. (24) 
 
Simian Virus 40 Replication 
 SV40 chromosomes contain a single origin of replication (ori) located within the 
regulatory region and is 64 bp (nt 5211-31) in length.  Replication occurs in both directions from 
the ori and terminates at approximately 180 degrees around the circular genome from the ori 
where the two replication forks meet. (28)  T-antigen, which was described earlier is involved in 
replication in two primary ways.  Firstly, it binds to SV40 DNA near the origin of replication and 
acts to recruit other needed proteins for replication.  Secondly, it has the ATPase and helicase 
activity required to unwind DNA during replication.  Interestingly, other than T-antigen all of the 
proteins necessary for replication and chromatin assembly are host derived. 
 
Simian Virus 40 Transcription 
 For what is known about transcriptional regulation in SV40 it closely resembles what has 
been seen in eukaryotic and viral systems, making it an ideal model system to study transcription.  
The regulatory region contains the DNA sequences required to control initiation of transcription.  
Specific DNA sequences in the regulatory region interact with host cell regulatory proteins tightly 
regulating this biological process, with many general transcription factors binding at SV40s 
'TATA'  box about 30 bp upstream from the transcription initiation site.  Early transcription is 
regulated by the early promoter, which can bind T-antigen.  The binding of T-antigen prevents 
14 
 
the binding of other required proteins required for early transcription, effectively downregulating 
early transcription. (29)  Repression of early transcription allows the focus of transcription to fall 
up the late transcript products, resulting in the production of VP1-3 and angoprotein. 
 
SV40 in relation to other polyoma viruses 
Polyoma viruses are small and have closed circular double stranded DNA of around 5.3 
Kbases.  SV40 is the most extensively researched polyoma virus due to its initial discovery of 
SV40’s ability to both transform cells and cause tumors in newborn mice. Along with SV40, 
polyoma viruses include mouse polyomavirus, human JC virus, human Merkel cell virus, and 
human BK virus, as well as others. (30) These viruses’ possess a region which contains both the 
origin of replication and transcriptional regulatory sequences. These regulatory sequences exert 
control over both the early and late genes which are located on either side of this region. (15) 
These viruses posses small genomes with limited encoding regions which when paired with their 












STATEMENT OF THE PROBLEM 
 Regulation of post-translational modifications, especially histone modifications, is 
critical for normal cellular function. Disregulation of these histone modifications has 
been known to be associated with many disease states and cancer types. The mechanism 
behind regulation of these modifications is not yet well understood. Understanding of 
these mechanisms will allow better insight into initiation and progression of specific 
disease states and cancer types.  
Most research on histone modification has focused on histone methylation.  
Histone methylation can be an immediate response to a biological process such as 
transcription; it can also provide stable, long term heritable epigenetic information to 
subsequent generations.  Methylation resulting from transcription is an example of intra-
generational epigenetic regulation, whereas passing epigenetic directing progeny to 
specific fates is an example of trans-generational epigenetic regulation. 
 Within the broad category of epigenetic regulation different input events can 
result in different epigenetic outcomes.  The problem is to determine which input events 
correlate with particular epigenetic outcomes, how these epigenetic outcomes are 
involved in the progression of the lifecycle of an infection, and how current 
environmental conditions can be transmitted to subsequent generations. 
This study has three goals:  
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(1) Determining the effects of replication and transcription on histone 
methylation. 
(2) Understanding the epigenetic progression in the lifecycle of an 
infection. 


















MATERIALS AND METHODS 
 
Cells and Viruses 
 SV40 virus and chromatin were prepared in the BSC-1 cell line of African green 
monkey kidney cells (ATCC). The 776 SV40 wild-type and cs1085 mutant virus were a 
gift from Dr. Daniel Nathans and the SM virus from Dr. Chris Sullivan.   PBM129-1 and 
pBM131-1 were created by Dr. Barry Milavetz, and the 39º epi-mutant created and 
grown in Dr. Milavetz's lab. 
 
Cell Culture 
African green monkey kidney BSC-1 cells were maintained in minimum essential 
medium (Gibco) and supplemented with 10% FBS (Gibco) and 1% gentamicin 
(Gibco)(10 mg/ml) in a 37°C NAPCO, Model 6200 CO2 Incubator.  Using sterile 
technique, all cell manipulations were done in a NUAIRE, Model NU 425-400 laminar 
air flow hood.  Media from tissue culture flasks (Corning 75 cm
2 
) containing confluent 
monolayers of cells was removed.  The cells were washed with 3 ml of 0.05% trypsin-
EDTA (Gibco) to remove protease inhibitors present in the growth media.  The wash was 
also removed and 5 ml of free trypsin-EDTA was added to the flask and allowed to 
incubate at 37° for 1-2 minutes.  Cells were then dislodged from the surface of the flask 
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by gentle tapping.  Confirmation of cell detachment was checked using an Olympus CK 
10 light microscope.  Aliquots of the trypsin-EDTA solution containing the dislodged 
cells was removed then a 1 ml aliquot was introduced into each of the two new tissue 
culture flasks each containing 20 ml of fresh growth media for the expansion of the 
culture.  20 ml of fresh media was added to the original flask which still contained 1 ml 
of the trypsin-EDTA dislodged cells.  The 3 flasks were then returned to the NUAIRE 
incubator and allowed to grow.  The average time between subcultures was 2-3 days. 
 
Infection of BSC-1 Cells 
 For the preparation of high titer working stocks of SV40 virus for subsequent 
studies, the following procedure was used.  One ul of the virus to be cultured was added 
to the media in a large (75 cm
2
 ) T-flasks containing confluent monolayers of cells.  The 
T-flasks were maintained at 37°C in a NAPCO Model 5100 incubator for approximately 
2-3 weeks or until a vast majority of the cells were dead.  The fluid was then placed in a 
50 ml Corning centrifuge tube and frozen at -20°C.  Verification of the presence of 
competent virus and to approximate the titer the HIRT method (described below) was 
performed prior to use.  The 50 ml tubes were centrifuged at 3000 X G at 4°C for 10 
minutes using a Beckman J6-MI centrifuge and the supernatant was placed into a new 50 
ml centrifuge tube and the contents were divided into 1 ml aliquots for future use and 
stored at -20°C. 
 
Isolation of Viral DNA 
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 In order to determine if newly prepared virus was suitable for use in future 
experiments the amount of viral DNA produced in a typical infection was determined for 
each batch of virus.  A batch is defined as coming from the same initial T75 flask as 
mentioned above.  For these analyses, small T-flasks (25 cm
2
) containing confluent 
monolayers of cells were used.  333 ul of thawed virus was added to the medium and the 
T-flasks were incubated for 48 hours at 37°C in a NAPCO Model 5100 incubator.  The 
viral DNA was harvested from the plate using 300 ul of lysing solution with gentle 
swirling to disrupt the infected cells.  The disrupted cell solution was added to a 1.5 ml 
microfuge tube followed by 100 ul of 5 M NaCl and gently vortexed.  The tube was 
refrigerated at 4°C overnight.  The next morning the tube was centrifugred at 14,000 x G 
at 4°C for 30 minutes.  The pellet was removed from the tube using a sterile wooden 
applicator stick and discarded.  The supernatant was then purified and PCRed as 
described below. 
 
Infection of BSC-1 Cells for the Preparation of SV40 Chromosomes 
Large T-flasks containing confluent monolayers of BSC-1 cells were infected with virus 
using sterile techniques in a Nuaire Model NU 425-400 laminar flow hood that was 
located seperately from the flow hood used for cell culture.  First, nine ml of the medium 
from the T-flasks to be used were decanted into a 15 ml disposable centrifuge tube.  Any 
remaining medium in the flask was discarded.  The 9 ml of medium was then returned 
into the T-flask.  Immediately prior to infection, one ml of the desired virus was thawed 
and transferred to the above T-flask containing 9 ml of medium and the flask was gently 
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swirled to mix virus throughout the media.  To allow the virus to bind, the cells were 
incubated at 37°C for 30 minutes.  Following virus adsorption to the cell, infected cells 
were either harvested immediately for 30 minutes chromosomes or washed twice with 5 
ml of 37°C serum-free medium to remove any unbound virus from the media.  The T-
flasks were returned to the incubator after the addition of 10 ml serum-free medium.  The 
infected cells were harvested after the desired period of incubation. 
 
Preparation of SV40 Nuclei 
 After infected cells were incubated for the desired period cells were washed with 
around 4 ml of 4° PBS solution two times, both times pipetting the remaining PBS from 
the flask to insure complete removal.  14 ml of chromosome preparation nuclei buffer 
was placed in a 15 ml Corning centrifuge tube.  One ml of the chromosome preparation 
nuclei buffer was placed in a sterile tube for later use.  Another one ml of the nuclei 
buffer was removed from the centrifuge tube and added to the flask.  The cells were 
gently scraped from the bottom of t he flask using a Cell Scraper. 0.05% Trition X-100 
was added to the flask and was used to wash the sides of the flask and to collect the 
nuclei in the corning of the flask.  The contents were collected with a 1 ml pipette and 
layered gently on top of the remaining 12 ml of nuclei buffer in the 15 ml centrifuge tube.  
The one ml of chromosome preparation nuclei buffer previously set aside was added to 
the flask and used to rinse the sides to collect any remaining nuclei, which was then 
collected and added to the 15 ml centrifuge tube.  The tube was centrifuged at 1,500 x G 
for 10 minutes at 4ºC in a Beckman Model J6-MI centrifuge, the supernatant was 
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decanted and excess liquid was removed from the pellet with a 200 ul pipette.  The 
nuclear pellet was frozen and stored at -20°C. 
 
Nuclear Extraction 
 The nuclear pellet was thawed, resuspended in 100 ul of chromosome extraction 
buffer, transferred to a sterile microfuge tube, and centrifuged at 12,000 x G at 4°C for 
30seconds.  The supernatant was removed with a pipette and discarded.  The pellet then 
had 200 ul of chromosome extraction buffer added to the tube and vortexed for 15 
seconds to break up the pellet.  The solution was then subjected to a 60 minute extraction 
at 4°C.  After the incubation the contents were centrifugred at 12,000 x G at 4°C for 30 
seconds then the supernatant was removed and placed in a sterile microfuge tube and 
stored at -20°C. 
 
Chromosome Purification 
100 ul of chromosome isolation buffer with 50% glycerol was placed in a 
microcentrifuge tube and stored at -20°C for at least 4 hours.  1 ml of chromosome 
isolation buffer with 10% glycerol was then gently layered on top of the 50% glycerol.  
The 200 ul nuclear extract was thawed and carefully layered on top of the 10% glycerol 
layer before being centrifuged using a TLA 100.3 rotor at 50,000 rpms for 35 minutes at 
4°C in a Beckman TLA 100 ultracentrifuge.  400 ul was gently removed from the top of 
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the tube and discarded.  600 ul more was removed gently from the top and stored at -
20°C. 
 
Sodium Butyrate (NaBt) Treatment 
 Cells were infected as previously described.  For the preparation of 12 hour NaBt 
treated chromosomes at 30 minutes post-infection following the addition of the fresh 
serum-free media the cells were treated with 250 uM of NaBt (25 ul of 1 M NaBt to a 
flask with 10 ml media) and incubated until 12 hours post-infection at 37°C.  At 12 hours 
post-infection the cells were harvested as previously described.  For the preparation of 48 
hour NaBt treated chromosomes infected cells were treated at 24 hours post-infection 
cells with 250 uM of NaBt (25 ul of 1 M NaBt to a flask with 10 ml media) and incubated 
until 48 hours post-infection at 37°C.  At 48 hours post-infection the cells were harvested 
as previously described. 
 
5,6-Dichloro-1 beta-D-ribofuranosylbenzimidazole (DRB) Treatment 
 For the preparation of 2 hour DRB treated chromosomes cells were treated with 
200 uM of DRB (20 ul of 1 M DRB to a plate containing 10 ml media) at 2 hours prior to 
infection and were incubated at 37°C.  Cells were infected as previously described.  After 
adding the fresh media at 30 minutes post-infection DRB was reapplied to the same 
concentration of 200 uM and the cells were incubated at 37°C until 2 hours post-
infection.  At 2 hours post-infection the cells were harvested as previously described. 
23 
 
 For the preparation of 48 hour DRB treated chromosomes the cells were infected 
as previously described.  At 24 hours post infection the cells were treated with 200 uM of 
DRB (20 ul of 1 M DRB added to a plate with 10 ml media) and were incubated at 37°C 




 For the preparation of 48 hour aphidicolin treated chromosomes the cells were 
infected as previously described.  Aphidicolin was applied at a concentration of 6 uM at 
24 hours post-infection and incubated at 37°C until 48 hours post-infection.  At 48 hours 
post-infection the cells were harvested as previously described. 
 
Dual Treatment with DRB and Aphidicolin 
 For the preparation of 48 hour chromosomes dual treated with DRB and 
aphidicolin the cells were infected as previously described.  At 24 hours post-infection 
DRB was applied at a 200 uM concentration and aphidicolin was applied at a 6 uM 
concentration and the cells were incubated at 37°C until 48 hours post-infection.  At 48 
hours post-infection the cells were harvested as previously described. 
 
Chromatin Immunoprecipitation (ChIP) 
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 SV40 chromosomes were immunoprecipitated with specific antibodies using the 
reagents and the protocol supplied by Millipore with minor modifications.  Depending on 
the specific antibody used, either 7.5 ul or 10 ul of antibody was incubated with 125 ul of 
salmon sperm DNA/protein A agarose and 750 ul of ChIP dilution buffer for 5 hours at 
4°C with constant rotation.  After 5 hours of incubation the samples were centrifuged at 
1000 x G for 1 minute to pellet the agarose, and the supernatant was discarded.  800 ul of 
ChIP dilution buffer was added to the agarose pellet along with 100 ul of chromtain.  The 
mixture was then incubated from 7-12 hours at 4°C with constant rotation.  Each tube 
containing immune complexes bound to protein A agarose was sequentially washed with 
low salt, high salt, lithium chloride, and two washes with Tris-EDTA (TE) buffer all 
supplied by Millipore according to their protocol.  Following resuspension of the protein 
A agarose with TE buffer for the second wash with the buffer, the suspension was 
transferred to a clean microcentrifuge tube.  Immune complexes were eluted from the 
protein A agarose by two sequential 15 minutes incubations in 110 ul of lysing buffer 
(0.6% SDS, 2 mm EDTA, pH 8.0) at room temperature.  After each incubation the 
protein A agarose was pelleted by centrifucation for 1 minute at low speed with the 
supernatant removed and stored at -20°C. 
 
Antibodies Used 
The antibodies used included: H3K4me1 (07 = 436, Millipore (Temicula, 
California, USA), H3K4me2 (39141, Active Motif Carlsbad, California, USA), 
H3K4me3 (04 = 745, Millipore Temicula, California, USA), H3K9me1 (ab9045, Abcam, 
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Cambridge Massachusetts USA), H3K9me2 (ab1220, Abcam, Cambridge, 
Massachusetts, USA), H3K9me3 (ab8898, Abcam, Cambridge, Massachusetts, USA), 
and RNA PII 905 = 623, Millipore,Temicula, California, USA). All antibodies were ChIP 
validated by the respective vendors. 
 
Immune-Selection Fragmentation Followed by a a second Immunoprecipitation (ISFIP)  
 A standard ChIP was performed as described above with the following changes.  
200 ul of input chromatin was used instead of the standard 100 ul.  After the second TE 
wash the protein A agarose was transferred to a new tube using 200 ul of TE buffer.  This 
resuspended agarose was sonicated with continuous pulse for 6 minutes in a cup horn at 
50% amplitude of 115 V + 10% using a Branson Digital Sonifier followed by brief 
centrifugation at 3000 rpms for 30 seconds to separate the supernatant from the agarose.  
The supernatant was then centrifuged again at 3000 rpms for 30 seconds to pellet out any 
remaining agarose.  This purified supernatant was used as the input for a second ChIP 
using a different antibody.  This second ChIP was done by the standard protocol 
previously described. 
 
Preparation of DNA for qPCR 
 Samples were prepared for PCR using an MP Bioscience Geneclean Spin Kit 
(#111101-200) with the following modifications.  The glassmilk reagent (100 ul) was 
mixed with 100 ul of sample in a 1.5 ml centrifuge tube.  The tube was mixed by repeated 
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inversion at 2 minutes and again at 4 minutes of incubation at room temperature.  
Following 5 minutes of incubation, the samples were centrifuged at 6000 rpm for 30 
seconds in a Micro One (Tomy) to pellet the glass.  The supernatant was discarded and 
200 ul of the wash buffer was added to the tube.  While adding the wash the pipette tip 
was used  to break up the pellet by both physically rubbing and vigorously pipetting up 
and down.  The samples were inverted twice and centrifugred at 6000 rpm for 30 seconds 
again to pellet the glass.  The supernatant was discarded and the pellets where dried in a 
vacuum for 5 min. The glass pellet with bound DNA was resuspended in 25 μl of Tris 
EDTA (TE) buffer.  
 
qPCR Amplification 
 DNA was amplified from the promoter region of the SV40 genome using the 
primers 5′-TTG CAA AAG CCT AGG CCT CCA AA-3′ and 5′-TGA CCT ACG AAC 
CTT AAC GGA GGC-3′ and from the early region using the primers 5'-
TGCTCCCATTCATCAGTTCC -3' AND 5'-CTGACTTTGGAGGCTTCTGG-3' in a 
CFX Connect Real Time System thermal cycler (Bio-Rad) using “SSO Advanced DNA 
polymerase” (Bio-Rad). Immediately before use, the primers and DNase free water were 
added and 28 μl of the mix was used per sample. Two microliters of the resuspended 
glass milk in TE buffer was added per sample. Samples were amplified by PCR in 
triplicate with a melt curve applied afterward to ensure specific amplification. All sample 
preparation for PCR was done in either a Nuaire biological safety cabinet Model 






SUMMARY OF RESULTS 
 
NOTE: All figures and tables for this section are located in their respective publications 
presented as individual chapters V-VII in this dissertation. 
 
 Great advances have been made in the understanding of histone modifications 
over the years.  Up until the early 1990s histones were thought to be only a highly 
efficient DNA storage protein. It is now clear that histones can have their individual 
amino acid side chains post-translationally modified.  Not only can different amino acids 
on histones be modified, but at least eleven different types of modifications are now 
known to be present on histones, including methylation, acetylation, propionylation, 
butyrylation, formylation, phosphorylation, ubiquitylation, sumoylation, citrullination, 
proline isomerization, ADP ribosylation, and crotonylation. (5) 
 The above mentioned post-translational modifications and their specific location 
on histones are known to play critical roles in many diverse biological processes, such as 
regulation of gene expression, to direct the fate of the individual cell, and thus the 
organism.  Many of the enzymes responsible for the addition and removal of these post-
translational modifications are also known now, such as the related G9a and GLP 
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proteins which are thought to methylate H3K9me2 and H3K9me3 in euchromatin, and 
the protein Suv39H1 which causes H3K9me3 methylation in 
heterochromatin.(31)(32)(33)(32,33),  While some of the proteins responsible to the 
addition and removal of post-translational modifications, such as lysine methylation, are 
now known a great deal remains to be understood about them in terms of their tightly 
controlled regulation and their diverse biological functions. (5) 
 The studies described in this dissertation used Simian Virus 40 (SV40) to examine 
post-translational modification introduction on histones under different conditions in 
order to further understand both the introduction of such modifications and also the 
biological outcomes of these modifications.  Levels of H3K4 and H3K9 methylation and 
actylation of histone 4 were measured and related to environmental conditions, active 
gene transcription, and productive genome replication in our model system. 
 Prior work on SV40 has shown that H3K4, H3K9, and histone H4 acetylation 
levels change over the course of the SV40 lytic infectious life cycle, starting with virions 
and transitioning from initial entry into the cell to late times in infection when future 
progeny are being replicated and encapsidated. (See Figure 1 in Chapter V) As 
hypothesized, these methylation modifications are not evenly distributed among the 
SV40 chromosomes but co-localize in distinct patterns, or epigenomes.  It has been 
known that cells differentiate and have different physical properties based on their 
ultimate gene expression as a result of this differentiation, even though they have 
identical genetic information.  This was the first evidence for viral chromosomes to also 
have different epigenomes, and at 48 hours post-infection at least 5 major epigenomes 
have been identified as shown in table 2 in Chapter V. 
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 In order to test if the epigenomes present at late times were related to biological 
properties of an infection a mutant (CS1085) containing a 30 bp deletion and defective 
for repression of early transcription was compared to wild-type SV40.  The deletion of 
Site 1 on CS1085 prevents the binding of T-antigen and results in the overproduction of 
early mRNAs that are normally repressed in a wild-type infection. (34)(35) Another 
mutant, SM (SV40 miRNA mutant), has a deleted regulatory miRNA which normally 
represses early gene expression.  The SM mutant results in an over-production of T-
antigen as a result of this mutation. (36) 
 These two mutants had noteworthy results.  Levels of H3K9me1 were strongly 
correlated with binding of T-antigen.  At 48 hours post-infection SM, which had 
increased T-antigen binding due to the increased presence of T-antigen, showed levels 
nearly double that of WT for H3K9me1, while CS1085 had H3K9me1 almost completely 
abolished (Table 3 in Chapter V).  This provides strong evidence that T-antigen binding 
results in the introduction of H3K9me1 at late times in infection, whether through 
modulation of the repression of transcription or through T-antigen recruiting 
methyltransferases.  While levels of H3K9me1 at 48 hours post-infection were increased 
in the SM mutant the levels of H3K9me1 in SM virions was reduced compared to WT 
virions, suggesting a different epigenome is responsible for encapsidation. (Table 4 in 
Chapter V) 
 Virions of the different mutants contained different epigenetic information stored 
on their encapsulated chromosomes.  If these differences in epigenetic information within 
virion particles were at least in part due to the different cellular environmental conditions 
resulting from the mutants used, it was hypothesized that other environmental conditions 
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might also affect the epigenetic information stored in virion progeny.  The environment 
was changed to 39ºC in order to partiality emulate a fever response to an infection.  The 
resulting virions contained distinct epigenetic information and had a greatly reduced yield 
(8% compared to WT) of genetic material at 48 hours post-infection resulting from an 
infection. CS1085 virions contained different epigenetic modifications compared to WT 
virions, and CS1085 infections produced 9% of the genetic material compared to a WT 
infection at 48 hours post-infection. (Figure 2A in Chapter V) 
While CS1085's Site 1 deletion would not have an effect on repression of early 
transcription as seen in WT infections it was unknown if the incoming chromosomes 
have any other differences that may result in altered properties that could play a role in 
effectively establishing a productive infection.  As seen in Figure 2B in Chapter V, 
CS1085 had approximately a 50% reduction in the effective transportation of its 
chromosomes into the nucleus, which could in part explain CS1085's diminished 
effectiveness.  Surprisingly, CS1085 was completely able to avoid degradation of its 
genetic material by cellular defenses, whereas WT infections resulted in 80% of the viral 
material in the nucleus being degraded from 30 minutes to 8 hours post-infection. (Figure 
2C in Chapter V) The exact cause of CS1085's ability to evade degradation by cellular 
defenses is currently unknown.   
 When using CS1085 to determine the effect of early transcription on epigenetic 
marks it was discovered that at different times different epigenetic outcomes resulted 
from T-antigen binding. (37) At early times when only early transcription was occurring 
T-antigen's binding caused an inhibition of H3K9me2 introduction, (Figure 5 in Chapter 
VI)  yet when replication was occurring at late times in infection when replication was 
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also occurring T-antigen caused the incorporation of H3K9me1 (Figure 4 in Chapter VI).  
To confirm this increase in H3K9me1 at late times was a result of T-antigen binding and 
not some other process a recombinant was created containing two copies of Site 1. In this 
construct, a second copy of Site was added and was located about 180º from the WT Site 
1 location, and the construct had increased levels of H3K9me1 present on its 
chromosomes late times in infection, suggesting that Site 1 can function similar to an 
enhancer when directing the epigenetic affects on its chromosome.(38) (Figure 6 in 
Chapter VI) 
 We have presented strong evidence that T-antigen binding at late times results in 
the incorporation of H3K9me1, yet at early times inhibits the introduction of H3K9me2.  
This suggests that at late times in infection T-antigen's ability to incorporate H3K9me1 is 
related to DNA replication.  Our lab has previously shown an association between 
actively replicating chromosomes and H3K9me1. (39)  This research shows a second 
independent confirmation of this relationship by inhibiting replication with aphidicolin.  
The increase in H3K9me1 normally seen when replication was occurring was completely 
prevented when replication was inhibited.  H3K9me3 incorporation still occurred even in 
the absence of replication, consistent with previous data showing that H3K9me3 uses 
H3K9me1 as a precursor independent of active replication.(40) (Figure 7 in Chapter VII)  
It is currently unclear how T-antigen binding blocks the incorporation of H3K9me2 at 
early times.  T-antigen has different biologically epigenetic effects at different times and 
when active replication is inhibited, suggesting multiple distinct mechanisms related to 
the biological processes of early transcription and active replication in which histone 
modifications can be incorporated. 
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  Expanding upon the inhibition of replication, transcription was repressed 
at both early and late times to determine its epigenetic effects.  DRB, an inhibitor of 
RNAPII elongation, was used at two hours pre-infection with chromosomes being 
harvested at 2 hours post-infection, and also at 24 hours post-infections with 
chromosomes being harvested at 48 hours post-infection, in order to capture 
transcriptional repression in both the absence and presence of active replication. The 
results obtained as a result of transcriptional repression through the use of DRB both in 
the presence and absence of active replication tie the increase of H3K9me2 and 
H3K9me3 to chromosomes containing RNAPII but only when DNA replication is active. 
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Abstract 
In eukaryotes, epigenetic information can be encoded in parental cells through 
modification of histones and subsequently passed on to daughter cells in a process known 
as transgenerational epigenetic regulation. Simian Virus 40 (SV40) is a well-
characterized virus whose small circular DNA genome is organized into chromatin and, 
as a consequence, undergoes many of the same biological processes observed in cellular 
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chromatin. In order to determine whether SV40 is capable of transgenerational epigenetic 
regulation, we have analyzed SV40 chromatin from minichromosomes and virions for the 
presence of modified histones using various ChIP techniques and correlated these 
modifications with specific biological effects on the SV40 life cycle. Our results 
demonstrate that, like its cellular counterpart, SV40 chromatin is capable of passing 
biologically relevant transgenerational epigenetic information between infections. 




Epigenetic regulation through covalent modification of histones has been shown 
to play a critical role in a number of important biological processes including cell fate 
determination during differentiation,(41)(42)(43)(44)(45) regulation of gene 
expression(46,47)(47) and the development of cancer. (48)(49)(50)(51) Importantly, all 
of these examples of epigenetic regulation are characterized by the transfer of epigenetic 
information from parental cells to daughter cells during cellular division. 
Simian Virus 40 (SV40) is a DNA tumor virus that is organized into chromatin in 
the intracellular minichromosome and virion, and undergoes hyperacetylation of H3 and 
H4 during transcription (52)(13)(53) and methylation of H4K20 during an infection. (54) 
Because of its similarity to cellular chromatin, we hypothesized that SV40 should be able 
to transfer epigenetic information recapitulating the conditions of an infection to a 
subsequent infection through the infecting virions. We tested this hypothesis by 
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characterizing the histone tail modifications in SV40 chromatin derived from 
minichromosomes and virions using ChIP analyses and correlating the observed 
variations in histone modification in the SV40 chromatin with subsequent effects on an 
infection. 
Extending our previous results,(54) we analyzed SV40 wild-type chromatin for 
the presence of methylated H3K4 and H3K9 during an infection, with the results shown 
in Figure 1. When SV40 chromatin was analyzed for the presence of methylated H3K4 
(Fig. 5A), we observed mono, di and trimethylated H3K4 present at 48 h post-infection 
(PI), but little, if any, methylated H3K4 at other times. When SV40 was analyzed for the 
presence of methylated H3K9 (Fig. 5B), all three of the methylated forms of H3K9 were 
present in SV40 chromatin throughout the course of the infection, including disrupted 
virions, with the exception of H3K9me2 at 24 h PI, which was only present at low levels. 
If the identified histone modifications actually represented epigenetic information, 
we expected that the modifications would be organized in the same way as in cellular 
chromatin, i.e., into various specific combinations (55) that would reflect the biological 





Figure 1. Methylated H3K4 (A) and H3K9 (B) are present in SV40 chromatin during a 
lytic infection. Unfixed SV40 minichromosomes were isolated from disrupted virions and 
infected cells at 30 min, 8 h, 24 h, and 48 h post-infection (PI), subjected to chromatin 
immunoprecipitation with 7.5 µl of antibody to each target modified histone, and the 
resulting immunoprecipitates amplified by PCR with primers recognizing the SV40 early 
region as previously described. (A) Lane 1, IgG; Lane 2, H3K4me1; Lane 3, H3K4me2; 
Lane 4, H3K4me3; Lane 5 Hyperacetylated H4; Lane 6, 5% of input SV40 chromatin. 
(B) Lane 1, IgG; Lane 2, H3K9me1; Lane 3. H3K9me2; Lane 4, H3K9me3; Lane 5 
Hyperacetylated H4; Lane 6, 5% of input SV40 chromatin. DNA present in 
immunoprecipitates from virions and minichromosomes isolated 48 h PI was amplified 








SV40 minichromosomes were analyzed by a two-step ChIP process in which the 
minichromosomes were first immune selected with an antibody to a specific form of 
modified histone, the chromatin was fragmented, and the resulting fragments subjected to 
a second ChIP with an antibody to a different modified histone. If two modified forms of 
histones were found on the same minichromosomes, we would expect to see that a 
significant fraction of the input chromatin from the first ChIP would be bound in the 
second ChIP with antibody to the second form of modified histone. Table 2 shows the 
result of this analysis. 
Based upon these results, we believe that there are at least five major SV40 
epigenomes present in cells infected with wild-type virus at 48 h post-infection. One 
consisted primarily of H3K4me2 in conjunction with H3K9me1, H3K9me2, H3K9me3, 
and hyperacetylated H4 (HH4). A second form also consisted primarily of H3K4me2 but 
in conjunction with HH3 and HH4. This conclusion was based upon the fact that H3K9 
cannot be methylated and acetylated at the same time, which we experimentally 
confirmed. A third epigenome consisted almost solely of H3K4me3 with some HH4 also 
present. The fourth epigenome consisted of H3K9me1 along with H3K9me2, H4K20me1 
and HH4. The fifth epigenome consisted primarily of H3K9me3 with trace amounts of 
other modifications. 
While this is the first demonstration that multiple distinct viral epigenomes 









Co-localization of modified histones on SV40 minichromosomes 
 





















































































HH3 + None None None + 
 
None, less than 10% of input; Trace, 10–20% of input; +, 20–30% of input; ++, over 30% 
of input. SV40 chromatin is organized into distinct epigenomes late in infection. SV40 
minichromosomes isolated 48 h PI were immune-selected with antibody to a 
modification of interest, the bound SV40 chromatin fragmented, and the fragments 
subjected to a second ChIP with antibody to a second modification of interest. The DNA 
present in the immunoprecipitates from the second ChIP was amplified for 32 to 40 
cycles depending upon the amount of chromatin present in the immuno-selection step 
with primers recognizing the early region of the SV40 genome. The amount of co-
localized modified histones were approximated from the semi-quantitative PCR using 
densitometry and confirmed by real time PCR. Each analysis was performed at least 
twice using different preparations of SV40 minichromosomes. The table represents the 




the co-localized modified histones are in agreement with previously reported results for 
cellular chromatin. For example, H3K9me1 has been previously shown to be co-localized 
within nucleosomes of transcribing regions with H3K4me1/2/3, H3K79me1/2/3 and 
H4K20me1 using a genome-wide strategy. H3K9me3 was found associated with 
H3K9me2 and H3K27me2/3 in silenced regions. (55)(56) 
In order to test whether the modified histones in epigenomes present at late times 
reflected biological properties of the infection, we analyzed wild-type and mutant SV40 
minichromosomes defective for the repression of early transcription for the presence of 
modified histones. The SV40 mutant cs1085 contains a 30 bp deletion of T-antigen 
binding Site I within the regulatory/promoter region and, as a consequence, does not 
repress early transcription as seen in a wild-type infection. (34)(35) This deletion results 
in an over-production of early mRNA and protein. We have previously exploited this 
aspect of cs1085 to investigate nucleosome phasing (57) and RNA polymerase II 
occupancy in transcribing SV40 minichromosomes. (52) SV40 early expression is also 
regulated by a miRNA found in the late region of the genome.(36) A mutant, SM (SV40 
miRNA mutant), deleted for the regulatory miRNA without affecting any other aspects of 
the virus, was shown to result in the over-production of T-antigen during infection.(36) 
We hypothesized that if one or more of the histone modifications observed in the 
epigenomes at 48 h PI in a wild-type infection was the result of T-antigen binding to Site 
I and subsequent repression of early transcription, these modified histones would likely 
be absent or significantly reduced in cs1085 minichromosomes late in infection. 
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Alternatively, if any of the histone modifications were a result of overexpression of T-
antigen one might expect similar effects by both mutants. 
SV40 minichromosomes were prepared at 48 h PI from cells infected with wild-
type, cs1085, or SM virus and analyzed for the presence of methylated H3K4 and H3K9. 
The levels of the various modified histones in each of the minichromosomes were then 
quantitated by real time PCR and compared as shown in Table 3. In the absence of T-
antigen mediated repression in cs1085 infections, we observed the greatest reduction in 
the amount of H3K9me1, and significant reductions in the amount of H3K4me1 and 
H3K4me2. In contrast, in the minichromosomes from SM virus infections with over-
production of T-antigen, we observed increases in the amounts of H3K9me1, H3K9me2 
and H3K9me3. These results indicated that T-antigen mediated repression of early 
transcription had its primary effect on the introduction of H3K9me1, a modification 
thought to be associated with repression in other eukaryotes.(58)Unexpectedly, T-antigen 
mediated repression also appeared to have an effect on the introduction of H3K4me1 and 
H3K4me2 into SV40 minichromosomes, modifications generally thought to be associated 
with transcriptional activation.(58) Based upon these results, it would appear that the 
epigenome containing large amounts of H3K9me1 along with H3K4me1/2 was mostly 
likely associated with repression of early transcription. 
We then directly tested the hypothesis that SV40 virions could carry epigenetic 
information by analyzing the histone modifications present in chromatin from virions. If 
the virions carried epigenetic information one would expect the patterns of histone 






Presence of modified histones in SV40 minichromosomes 
 
Chromosome H3K4me1 H3K4me2 H3K4me3 H3K9me1 H3K9me2 H3K9me3 HH4 
Wt 776 
 
0.1 ± 0.07% 
 
0.4 ± 0.3% 
 
0.08 ± 0.06% 
 
22 ± 10% 
 
0.04 ± 0.03% 
 
12 ± 6% 
 




0.005 ± 0.007% 
 
0.02 ± 0.02% 
 
0.02 ± 0.02% 
 
0.66 ± 0.6% 
 
0.17 ± 0.2% 
 
8.2 ± 5% 
 
2.7 ± 2% 
 
SM 0.02 ± 0.01% 0.5 ± 0.4% 0.13 ± 0.13% 39 ± 9% 0.93 ± 0.7% 18 ± 9% 13 ± 1% 
 
 
Histone methylation is partially controlled by SV40 T-antigen late in infection and 
epigenetically propagated in virions. SV40 chromatin was isolated 48 h PI from cells 
infected with wild-type, cs1085, or SM mutant viruses. SV40 chromatin was also 
prepared from the corresponding disrupted virions and virions prepared at elevated 
temperature. The SV40 chromatin was subjected to ChIP analyses with antibodies to each 
of the methylated forms of H3K4 and K3K9, and the DNA present in the resulting 
immunoprecipitates quantitated by real time PCR. Analysis of wild-type, cs1085, and SM 




contrast, if the pattern present in the virions was a result of other biological 
processes, one might expect the pattern in the virions to be independent of the patterns 
present in the minichromosomes. Virions were purified, disrupted with DTT, the 
chromatin present in the disrupted virions purified from intact virions,(54) and analyzed 
for the presence of modified histones with the results shown in Table 4. Compared with 
the pattern of H3K9 methylation and HH4 acetylation in wild-type chromatin from 
virions, we observed a significant reduction in the percentage of chromatin containing the 
three methylated forms of H3K9 and HH4 in cs1085 and a significant reduction in the 
percentage of H3K9me2, H3K9me3 and HH4 in the SM mutant. While the pattern of 
changes in the virions closely mirrored the pattern of histone modifications in the cs1085 
minichromosomes, the pattern for the chromatin in SM virions did. Nevertheless, both 
mutants displayed patterns of histone modifications in the virions that were very different 
from the wild-type virion chromatin and each other, indicating that in each case the virion 
chromatin carried distinct epigenetic information. 
Next, we confirmed that the pattern of histone modifications in virion chromatin 
reflected aspects of the infection by comparing virions produced at 37°C and 39°C. Since 
the SV40 DNA sequence is identical at both temperatures, any changes in the pattern of 
histone modifications in the virions must be a result of epigenetic changes. As shown in 
Table 4, the pattern of histone modifications for virions produced at 39°C was distinct 
and differed from the results obtained from the wild-type virions and both mutants 
particularly with respect to the amount of H3K9me3. These results were consistent with 
the hypothesis that the conditions of an infection contribute to the epigenetic 
modifications appearing in the virions produced during that infection. 
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 Table #4 
 
               Presence of modified histones in SV40 virions 
 
Chromosome H3K9me1 H3K9me2 H3K9me3 HH4 
Wt 776 
 
2.9 ± 1% 
 
1.9 ± 0.8% 
 
0.9 ± 0.4% 
 




0.20 ± 0.1% 
 
0.14 ± 0.1% 
 
0.13 ± 0.09% 
 




1.8 ± 0.8% 
 
0.08 ± 0.03% 
 
0.29 ± 0.15% 
 
0.43 ± 0.16% 
 
776 (39°C) 3.1 ± 1.8% 0.81 ± 0.3% 3.4 ± 2% 0.93 ± 0.4% 
 
Histone methylation is partially controlled by SV40 T-antigen late in infection and 
epigenetically propagated in virions. SV40 chromatin was isolated 48 h PI from cells 
infected with wild-type, cs1085, or SM mutant viruses. SV40 chromatin was also 
prepared from the corresponding disrupted virions and virions prepared at elevated 
temperature. The SV40 chromatin was subjected to ChIP analyses with antibodies to each 
of the methylated forms of H3K4 and K3K9, and the DNA present in the resulting 
immunoprecipitates quantitated by real time PCR. Analysis of chromatin obtained by 





If the patterns of modified histones present in chromatin from virions represented 
inheritable epigenetic information, we expected that this epigenetic information would 
affect aspects of a subsequent infection. In order to test this hypothesis, we analyzed 
infections by the various viruses for the yield of SV40 DNA at 48 h PI as a measure of 
infection efficiency. SV40 DNA in virions and infected cells was isolated by the Hirt 
procedure (59) and measured by real time PCR. All comparative infections contained the 
same amount of input SV40 DNA in the pool of infecting virus. Consistent with our 
hypothesis that the viruses contained inheritable epigenetic information, in comparison to 
the wild-type virus prepared at 37°C, whose amount was set at 100%, we observed only 9 
± 2% for cs1085, 31 ± 7% for SM and 8 ± 1% for the virus prepared at 39°C (Fig. 6A). 
Since the epigenetic information encoded in the histone modifications present in 
virion chromatin is first made available for reading following uncoating of the virus 
particle, we hypothesized that this epigenetic information might have an effect on the 
early stages of the establishment of an infection. In order for an SV40 infection to be 
established, virions must be transported through the cytoplasm, presented to the nuclear 
pore complex, and the protein coat of the virion removed or substantially modified so that 
cellular factors can access the chromatin to initiate early transcription. (60)(61) In a 
competing process, we have previously reported that a significant fraction of incoming 
viral chromatin is targeted for degradation by the cell. (54) 
In order to test whether the observed differences in wild-type and cs1085 
epigenetic information affected transport to the nucleus or cellular degradation of viral 
chromatin, we measured by real time PCR the amount of SV40 DNA present as 






Methylation of histone H3 affects infectivity and stability of infecting SV40 chromatin. 
Cells were infected with equal amounts (based upon real time quantitation of the SV40 
DNA present in virions) of wild-type 776, cs1085, SM or 776 grown at 39°C virus. SV40 
DNA or minichromosomes were isolated at the times indicated and quantitated by real 
time PCR. (A) Yield of SV40 DNA at 48 h PI following infection with wild-type 776, 
cs1085, SM virus or 776 grown at 39°C. (B) SV40 DNA present in cells or nuclei 
infected with equal amounts of 776 or cs1085 virus at 30 min PI. C. SV40 DNA present 




SV40 viruses. For these studies, nuclei were prepared according to our standard 
protocol, which was originally optimized for the yield of biologically active SV40 
minichromosomes.(62) As shown in Figure 2B, a significantly smaller percentage of 
infecting SV40 chromatin was found in the nucleus following infection with cs1085 
compared with wild-type virus at 30 min PI indicating that the epigenetic information 
carried by the two viruses had an effect on import into the nucleus. The epigenetic 
information carried by the infecting virions also had an effect on cellular degradation of 
the SV40 chromatin. As shown in Figure 2C, wild-type chromatin was degraded 
approximately 75% between 30 min and 8 h when measured in either whole cells or 
nuclei, consistent with our previous results,(54) while cs1085 chromatin appeared to be 
resistant to degradation (Fig. 6C). These results indicate that both the passage through the 
nuclear pore complex and the degradation of the incoming viral chromatin are sensitive 
to the specific epigenetic information carried by the viral chromatin. 
While this first demonstration of virion-dependent transfer of biologically 
relevant epigenetic information between infections utilized SV40, which is generally 
thought to be nonpathogenic in humans, it is very likely that other DNA viruses that are 
organized into chromatin and are pathogenic (e.g., papillomaviruses) will also show this 
behavior. For those viruses that utilize epigenetics in the establishment of an infection, 
these results suggest that this process is much more complex and more highly regulated 
than previously thought. Finally, the results with SV40 virions prepared at elevated 
temperature indicate that fevers during viral infection may affect the disease process 




Materials and Methods 
Cells, viruses and infections 
SV40 DNA and minichromosomes were prepared in the BSC-1 cell line (ATCC) 
using wild-type 776 (from Dr. Daniel Nathans), cs1085 (from Dr. Daniel Nathans) or SM 
virus (from Dr. Chris Sullivan). Uninfected cells were maintained at 37°C in minimal 
essential medium containing 10% (v/v) fetal calf serum, gentamycin, glutamine, and 
sodium bicarbonate (GIBCO) as previously described. (52)(13)(53) Sub-confluent cell 
mono-layers were exposed to virus for 30 min, the virus containing medium removed, the 
plates washed twice with fresh warm medium, 10 ml of fresh (52)(13)(53) SV40 
minichromosomes were prepared in 75 cm2 T- flasks containing a total of 10 ml of 
medium, while experiments in which SV40 DNA was prepared were performed in 25 
cm2 T-flasks containing 3 ml of medium. Comparative infections with either different 
viruses or for different periods of infection were performed in parallel at the same time. 
Preparation of SV40 DNA, Nuclei and Minichromosomes 
Total SV40 DNA present in infected cells was prepared according to the Hirt 
procedure.(59) Briefly, the medium was removed from the infected cells, the cells 
washed twice with cold PBS, and 0.3 ml of lysing solution (0.6% SDS, 10 mM EDTA) 
added. The flask was rocked for a few minutes until all the cells in the flask appear to be 
solubilized and the solution transferred to a 1.4 ml Eppendorf tube. Following transfer the 
flask was washed with 0.2 ml of PBS and the wash added to the 0.3 ml transferred to the 
tube. 160 µl of 5M NaCl was added to the tube and the tube inverted 20 times to mix the 
contents. After storage overnight at 4°C, the tube was spun at 16,000 x G at 4°C for 30 
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min, and the soluble contents removed from the cellular DNA pellet. The soluble fraction 
was referred to as the Hirt supernatant and was used in subsequent analyses. 
The SV40 DNA present in the nuclei of infected cells was prepared from infected 
cells (25 cm2 T-flasks) by a modification of our previously described procedure for 
preparing SV40 minichromosomes. Nuclei were released from infected cells by a 
combination of scraping the cells in low-ionic strength buffer (0.5 ml) and TritonX-100 
(0.5 ml) as previously described(52)(13)(53) and the liquid transferred to a 1.4 ml 
Eppendorf tube. Any remaining cells in the flask were obtained by a second scraping 
treatment in low-ionic strength buffer (0.5 ml) and TritonX-100 (0.5 ml) and transfer of 
the liquid to a second Eppendorf tube. The tubes were spun at 16,000 x G for 30 sec and 
the supernatant removed. The pellet in each tube was suspended in 0.2 ml of low-ionic-
strength buffer, the supernatants combined and gently layered onto a new tube containing 
0.6 ml of low-ionic-strength buffer. Following centrifugation at 5000 x G for 10 min, 
then supernatant was removed and the pellet resuspended in 0.2 ml of PBS. Lysing 
solution (0.3 ml) was added followed by 0.16 ml of 5M NaCl. The tube was inverted 
about 20 times and placed overnight at 4°C. The next day the tube was spun at 16,000 x 
G for 30 min at 4°C in an Eppendorf Model 5415 C centrifuge. The supernatant was 
transferred to a new tube labeled nuclear portion and the pellet was discarded. SV40 
minichromosomes were prepared from infected cells and purified on glycerol step 
gradients as previously described. (52)(13)(53) Gradient fractions 3 through 5 were 
pooled for subsequent analyses. 
Preparation of SV40 Chromatin from Virions 
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SV40 virus was prepared by infecting cells with 0.005 plaque-forming units of 
seed virus per cell in order to limit the amount of defective virus formed. Infected cells 
were incubated until approximately 99% of the cells were dead. Crude virus (1 ml) was 
transferred to a 1.4 ml Eppendorf tube and centrifuged in a Beckman TLA 100 
ultracentrifuge at 50,000 x G for 35 min at 4°C on 10% glycerol buffer (10 mM HEPES, 
5 mM KCl, 1mM EDTA, 0.2 mM MgCl2, 0.5 mM DTT, 10% glycerol). The pellet of 
virus and cellular debris was resuspended in 175 µl of TE buffer, and 20 µl of a 10X 
digestion buffer supplied by NEB added and 5 µl of DNaseI (NEB) added. Following 
incubation at 37°C for 15 min to allow the DNase I to degrade any non-virion forms of 
SV40 chromatin, the mixture was centrifuged as above in the TLA 100 ultracentrifuge on 
10% glycerol buffer. The pellet was resuspended in 194 µl of TE buffer, 6 µl of 5 M DTT 
was added, and the suspension incubated at room temperature for 15 min to disrupt the 
virions as previously described. (54) The mixture was again sedimented on 10% glycerol 
as described above. Fractions 2 through 5 which have previously been shown to contain 
SV40 chromosomes were pooled and used in subsequent analyses. 
Standard Chromatin Immunoprecipitation Analyses 
 All of the antibodies used in these studies were ChIP validated by the supplier and 
included H3K4me1 (07–436, Millipore), H3K4me2 (39141, Active Motif), H3K4me3 
(04–745, Millipore), H3K9me1 (ab9045, Abcam), H3K9me2 (ab1220, Abcam), 
H3K9me3 (ab8898, Abcam), H4K20me1 (39175, Active Motif), hyperacetylated H3 
(06–599, Millipore), and hyperacetylated H4 (06–866 Millipore). We also used an 
antibody recognizing H4K20me1 which was a gift from Dr. Thomas Jenuwein, which we 
previously showed functioned similarly to the commercial antibody. (54) Unfixed SV40 
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chromatin (100 µl) from infections and disrupted virions was immunoprecipitated with 
10 µl of antibody using the reagents and protocol supplied by Millipore in their kit for the 
analysis of hyperacetylated histone H4 with minor modifications. (52)(13)(53) 
Preparation of DNA for PCR Analyses 
 DNA samples for standard PCR were prepared by phenol/chloroform extraction 
followed by ethanol precipitation in the presence of paint pellet (Novagen) as previously 
described. (52)(13)(53) DNA samples for real time PCR were prepared by 
phenol/chloroform extraction and used directly in amplifications. DNA samples from 
ChIP elutions (10 µl) were mixed with 50 µl of phenol/chloroform (AM9730, Ambion) 
and TE buffer (70 µl). The mixture was vortexed for 10 sec and centrifuged for 10 min at 
8,000 x G in an IEC Micromax centrifuge. The aqueous phase (40 µl) was removed for 
subsequent PCR amplification. 
PCR Amplifications 
Purified DNA samples were amplified by standard PCR using primers which 
recognize the early region of the SV40 genome (5′GCTCCCATTCATCAGTTCCS3′ and 
5′CTGACTTTGGAGGCTTCTGG3′) as previously described. (52)(13)(53) 
Amplification was initiated with a hot start at 95°C for 2 min followed by 35 to 45 cycles 
of amplification. Each cycle consisted of an annealing step at 60°C for 1 min, DNA 
syntheses at 72°C for 1 min, and denaturation at 95°C for 1 min. 
Real Time PCR 
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SV40 DNA was amplified from the early region of the SV40 genome using the 
primers described above (0.3 µM) in a Bio-Rad MyIQ2 real time thermal cycler using the 
Power SYBr Green PCR master mix (Applied Biosystems). The amplifications were 
initiated by a hot start at 94°C for 15 min. The DNA was amplified for between 40 and 
50 cycles with each cycle consisting of annealing of primers at 60°C for 1 min, DNA 
synthesis at 72°C for 1 min, and denaturation of the DNA at 94°C for I min. All samples 
were analyzed in duplicate sets. 
Analysis of PCR Amplification Products 
Following standard PCR amplifications, amplification products were separated on 
2.4% submerged agarose gels (Sigma) by electrophoresis. (52)(13)(53) Amplification 
products were visualized by staining with ethidium bromide and digitally recorded using 
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Abstract 
Simian virus 40 (SV40) early transcription is repressed when the product of early 
transcription, T-antigen, binds to its cognate regulatory sequence, Site I, in the promoter 
of the SV40 minichromosome. Because SV40 minichromosomes undergo replication and 
transcription potentially repression could occur during active transcription or during 
DNA replication. Since repression is frequently epigenetically marked by the 
introduction of specific forms of methylated histone H3, we characterized the 
methylation of H3 tails during transcription and replication in wild-type SV40 
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minichromosomes and mutant minichromosomes which did not repress T-antigen 
expression. While repressed minichromosomes following replication were clearly marked 
with H3K9me1 and H3K4me1, minichromosomes repressed during early transcription 
were not similarly marked. Instead repression of early transcription was marked by a 
significant reduction in the level of H3K9me2. The replication dependent introduction of 
H3K9me1 and H3K4me1 into wild-type SV40 minichromosomes was also observed 
when replication was inhibited with aphidicolin. The results indicate that the histone 
modifications associated with repression can differ significantly depending upon whether 
the chromatin being repressed is undergoing transcription or replication. 
Keywords: simian virus 40, viral epigenetics, H3K9, H3K4, transcription, replication 
 
Introduction 
The selective methylation of the amino terminal tails of histone H3 and H4, a 
well-known form of epigenetic regulation, has been associated with a number of 
important biological regulatory processes including the control of transcription and 
cellular differentiation (41)(42)(46)(47)(43)(44)(45). Functionally, epigenetic regulation 
of transcription can occur either to control a particular gene’s expression during a cell’s 
life, or to pass along transcriptional information following cell division. The former 
would be an example of intra-generational epigenetic regulation while the latter would be 
an example of trans-generational regulation. While both forms of regulation might occur 
in association with a particular gene, it has not yet been established whether the same 
forms of histone methylation invariably mark the chromatin of the regulated gene during 
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intra-generational and trans-generational regulation, nor how these two forms of 
epigenetic regulation might be related. 
Since the passing of epigenetic information from a parental cell to daughter cells 
during cell division is critical to transgenerational epigenetic regulation, the mechanism 
of this inheritance has been the subject of much interest (63). A model for the inheritance 
of cellular transgenerational epigenetic information has emerged in which nucleosomes 
containing parental epigenetic information are randomly passed to daughter DNA during 
replication. These nucleosomes then act to direct the modification of histones present in 
the newly replicated nucleosomes added to the DNA in order to conserve the parental 
epigenetic modifications in the daughter chromatin (64)(65). 
Simian virus 40 (SV40), a member of the polyomavirus family, has been 
extensively studied as a model for eukaryotic molecular biology since its initial 
identification in 1960 because of its small size, organization into typical chromatin 
structure, and almost complete use of cellular enzymes and factors to complete its life 
cycle. A time course of SV40 transcription, replication, and encapsidation is shown in 
Figure 3. Upon infection the SV40 is rapidly transported to the nucleus with removal of 
the virus coat proteins and within 2 h early transcription begins. As the level of the major 
product of early transcription, T-antigen, increases it serves to repress its own expression 
through a feedback mechanism in which it binds to a site in the transcriptional regulatory 
region known as Site I. By 8 h post-infection repression of early transcription is 
extensive. Between 12 and 24 h post-infection late transcription and DNA replication 
begin with late transcription slightly preceding replication. At approximately 48 h post-
infection replication is maximal. Beginning at approximately 48 h, newly replicated 
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SV40 is bound by the products of late transcription, VP1, VP2, and VP3, to encapsidate 
new virus particles in a process which continues until the infected cell lyses and the 
newly synthesized virus is released (66). 
We have recently shown using a SV40 mutant which does not repress early SV40 
transcription, that repression is strongly associated at late times in infection with mono-
methylation of H3K9 and weakly associated at this time with mono-methylation of H3K4 
(37). Specifically, we compared the levels of methylated H3K4 and H3K9 at 48 h post-
infection in wild-type SV40 which represses early transcription and the mutant cs1085 
which contains a 30-bp deletion in the regulatory region encompassing T-antigen binding 
Site I and does not repress early transcription (35). We found that the percentage of SV40 
minichromosomes containing H3K9me1 was reduced from 22 ± 10% in the wild-type 
minichromosomes to 0.66 ± 0.06% in the mutant which fails to repress. Similarly, we 
observed a reduction in H3K4me1 from 0.1 ± 0.07% in wild-type minichromosomes to 
0.005 ± 0.007% in the mutant. In contrast, H3K4me2 went from 0.4 ± 0.3 to 0.02 ± 
0.02%, H3K4me3 went from 0.08 ± 0.06 to 0.02 ± 0.02%, H3K9me2 went from 0.04 ± 
0.03 to 0.17 ± 0.2%, and H3K9me3 went from 12 ± 6 to 8.2 ± 5% comparing the wild-
type to the mutant. Moreover, we also showed that the changes in methylation patterns 
which occurred in SV40 minichromosomes during infection in mutants or following 
other changes in environment could also be represented in the SV40 chromatin present in 
virions and transferred to a subsequent infection in the viral equivalent of trans-
generational epigenetic regulation (37). However, we do not know whether 
















effects on histone methylation. For this reason, we have extended our studies on early 
repression to early times in infection and characterized the changes which occur to the 
methylation patterns of SV40 minichromosomes. In addition, we have also investigated 
the role of DNA replication in introducing each of the methylated forms of H3K4 and 
H3K9. 
 
Materials and Methods 
Cells and Viruses 
Wild-type and mutant SV40 minichromosomes were prepared in the monkey 
kidney BSC-1 cell line (ATCC) using either wild-type 776 virus, cs1085 virus (from Dr. 
Daniel Nathans) or SM virus (from Dr. Chris Sullivan). The recombinants pBM129-1 and 
pBM131-1 were prepared in our laboratory and previously described (67). 
Cell Culture and Infection 
 BSC-1 cells were maintained and infected as previously described with the 
exception of incubating cs1085 virus with the cells for 1 h, in order to increase the 
minichromosome yield, instead of the typical 30 min (52)(37). SV40 minichromosomes 
were isolated at the indicated times post-infection as described for each of the analyses. 
DNA replication was inhibited with aphidicolin (final concentration 6 μM). Aphidicolin 
in ethanol (4 μl) was added at 24 h post-infection and minichromosomes were prepared 
from treated cells at 48 h post-infection. 
Preparation of SV40 Minichromosomes 
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SV40 minichromosomes were harvested at the desired time as previously 
described (52)(37)with one minor modification. After transferring the lysed cells to the 
15 ml centrifuge tube, an additional 1 ml of nuclei preparation buffer was used to rinse 
the flask and was subsequently added to the centrifuge tube in order to maximize the 
yield of minichromosomes from each infection. 
Chromatin Immunoprecipitation 
Chromatin immunoprecipitation (ChIP) kits were obtained from Millipore and the 
protocol was followed as previously described (37). The antibodies used included: 
H3K4me1 (07-436, Millipore), H3K4me2 (39141, Active Motif), H3K4me3 (04-745, 
Millipore), H3K9me1 (ab9045, Abcam), H3K9me2 (ab1220, Abcam), H3K9me3 
(ab8898, Abcam), and RNA polymerase II (RNAPII; 05-623, Millipore). All antibodies 
were ChIP validated by the respective vendors. Hundred microliters of protein A agarose, 
800 μl of ChIP dilution buffer, and 7.5 μl of each antibody was used in a protein low-bind 
tube. The mixture was rotated for 5 h at 4°C on an end to end rotator in a refrigerator to 
bind the antibody to protein A agarose. Following binding of the antibody, the protein A 
agarose was spun down at 2,000 × g for 2 min and the supernatant discarded. Eight 
hundred microliters of fresh ChIP dilution buffer was added and either 100 or 200 μl of 
the chromatin to be analyzed was added. The samples containing antibody bound to 
protein A agarose and chromatin were incubated with end to end rotation for a further 7 h 
at 4°C. The chromatin bound to protein A agarose was washed according to the 
manufacturer’s protocol and eluted as previously described (37). 
Preparation of DNA 
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 Samples were prepared for PCR using an MP Bioscience Geneclean Spin Kit 
(#111101-200) with the following modifications. The glassmilk reagent (100 μl) was 
mixed with 100 of sample in a 1.5-ml centrifuge tube. The tube was mixed by repeated 
inversion at 2 min and again at 4 min of incubation. Following 5 min of room 
temperature incubation, the samples were centrifuged at 6,000 rpm for 30 s in a Micro 
One (Tomy) to pellet the glass. The supernatant was discarded and 200 μl of the wash 
buffer was added to the tube. While adding the wash the pipette tip was used to break up 
the pellet by both physically rubbing and vigorously pipetting up and down. The samples 
were inverted twice and centrifuged at 6,000 × g for 30 s to again pellet the glass. The 
supernatant was discarded and the pellets where dried in a vacuum for 5 min. The glass 
pellet with bound DNA was resuspended in 25 μl of Tris EDTA (TE) buffer. 
PCR Amplification 
DNA was amplified from the promoter region of the SV40 genome using the 
primers 5′-TTG CAA AAG CCT AGG CCT CCA AA-3′ and 5′-TGA CCT ACG AAC 
CTT AAC GGA GGC-3′ in a CFX Connect Real Time System thermal cycler (Bio-Rad) 
using “SSO Advanced DNA polymerase” (Bio-Rad). Immediately before use, the primers 
and DNase free water were added and 28 μl of the mix was used per sample. Two 
microliters of the resuspended glass milk in TE buffer was added per sample. Samples 
were amplified by PCR in triplicate with a melt curve applied afterward to ensure specific 
amplification. All sample preparation for PCR was done in either a Nuaire biological 





 In order to test whether the repression of early transcription which occurs prior to 
replication was also associated with the same forms of histone methylation observed 
when replication was occurring, we used two distinct strategies. First, we determined 
whether there were changes in histone methylation during the first 8 h post-infection in a 
wild-type infection consistent with what we previously reported for repression of early 
gene expression late in infection during DNA replication (37). We hypothesized that if 
transcriptional repression occurring at early times was associated with mono-methylation 
(me1) of H3K9 as observed during DNA replication, we would observe an increase in 
H3K9me1 over the first hours of an infection perhaps approaching the 20% value seen at 
late times when transcriptional repression was occurring. In contrast if early 
transcriptional repression was not associated with mono-methylation of H3K9 we would 
expect no effect on the levels of H3K9me1. Since we previously reported that the fraction 
of SV40 minichromosomes containing RNAPII decreased during the first hours of 
infection consistent with the repression of early transcription (52), we first confirmed that 
this was the case. SV40 wild-type minichromosomes were isolated 2, 4, 6, and 8 h post-
infection and analyzed by ChIP for the presence of RNAPII. As shown in Figure 4A, we 
observed a slow and continual decrease in the percentage of RNAPII bound to SV40 
minichromosomes between 2 and 8 h post-infection. We next determined the percentage 
of minichromosomes isolated at 30 min, 2, 4, and 8 h which contained H3K9me1. We did 
not analyze for the presence of methylated H3K4 at these times because we have 
previously shown that minichromosomes contain very low levels of methylated H3K4 
(37). As shown in Figure 4B, we did not observe an increase in the level of H3K9me1 as 
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expected if it was associated with transcriptional repression. H3K9me1 remained present 
in approximately 1% or less of the minichromosomes at this time which was similar to 
the level that we previously reported present in the SV40 virus particles, 2.9 ± 1% (37), 
which was used for the infection. 
 Secondly, we determined whether infection by the mutant cs1085 which lacks 
Site I and fails to repress early transcription resulted in a changed pattern of histone 
methylation compared to wild-type virus during the same time. Again, we focused only 
on the methylated forms of H3K9 at this time because we have previously shown that 
there is very little if any methylated H3K4 at the very early times in question (37). SV40 
minichromosomes were prepared at the indicated times, subjected to ChIP analyses and 
the percentage of minichromosomes containing each methylated form of H3K9 
determined by real-time PCR. The data is represented as the percentage of 
minichromosomes containing the modification present at 8 h of infection divided by the 
percentage present at 30 min of infection. A ratio less than 1 indicates that the percentage 
of minichromosomes carrying a particular methylated H3 is reduced over this period. As 
shown in Figure 5, we observed that for both the wild-type and cs1085 mutant we 
observed a reduction in the relative amount of H3K9me1 and H3K9 tri-methylation  
(H3K9me3) present in minichromosomes between 30 min and 8 h post-infection. 
However, while the amount of H3K9 di-methylation (H3K9me2) was reduced during this 
period in the wild-type virus, the amount was significantly increased in the cs1085 
mutant. These results suggest that repression of early gene expression during active 











Repression of active early transcription does not result in an increase in H3K9me1. SV40 
wild-type minichromosomes were isolated between 30 min and 8 h post-infection, and 
subsequently subjected to ChIP analyses with antibodies to either RNA polymerase II 
(RNAPII) or H3K9me1. The percentage of the input minichromosomes containing either 
RNAPII (A) or H3K9me1 (B) was determined by real-time PCR for each time point 
analyzed. All analyses were performed a minimum of three times using different 




 In order to independently confirm that Site I was responsible for the introduction 
of H3K9me1 at late times but not early times, we compared the level of H3K9me1 in an 
SV40 recombinant containing two copies of Site I (pBM131-1) to a parental recombinant 
containing only a single copy of Site I (pBM129-1). We hypothesized that if Site I was 
responsible for the introduction of H3K9me1 in a replication dependent manner, we 
would observe an increase in the percentage of H3K9me1 in the recombinant compared 
to the parental virus at late times but not at early times when replication was not 
occurring. For these studies we used recombinant viruses originally prepared to study the 
ability of SV40 regulatory sequences to phase nucleosomes and generate nucleosome free 
regions in SV40 chromatin. The parental recombinant and its construction as well as the 
recombinant containing two copies of Site I have been previously described (67). The 
structures of both of these constructs are shown in Figure 5. The parental construct 
pBM129-1 has a single copy of Site I in the regulatory region as in the wild-type virus 
(Figure 6A). pBM131-1 has two copies of Site I, one located as in pBM129-1 and a 
second copy present in the reporter region as shown in Figure 6B. The results of this 
analysis are graphically represented in Figure 6C. As shown at 8 h post-infection when 
Site I should be active down-regulating early transcription we observed a ratio of 0.50 ± 
0.35 indicating that there was less methylation of H3K9me1 at this time in the 
recombinant carrying two copies of Site I than in the parental recombinant with only one 
copy. In contrast at 48 h post-infection when replication is occurring we observed a ratio 
of 1.66 ± 0.37 confirming that Site I is capable of directing the introduction of H3K9me1 
when SV40 is replicated. Interestingly it is also apparent that the second copy of Site I 





H3K9me2 is significantly increased during active early transcription in the site I deletion 
mutant cs1085. Wild-type and cs1085 SV40 minichromosomes were isolated from 
appropriately infected cells at 30 min and 8 h post-infection. Isolated minichromosomes 
were subjected to ChIP analyses with antibodies against H3K9me1, H3K9me2, and 
H3K9me3, and the percentage of input minichromosomes containing each form of 
methylated H3 determined by real-time PCR. The results are displayed as the ratio of the 
percentage of minichromosomes isolated at 8 h which contain a particular modification 
divided by the percentage of minichromosomes isolated at 30 min which contain the 
same modification. Ratios greater than 1 indicate that a modification is increasing during 
the period from 30 min to 8 h, while a ratio less than 1 indicates that the modification is 
decreasing during this period of infection. All analyses were performed a minimum of 







 Since the effect of repression on H3K9me1 was only seen at late times in 
infection, it seemed likely that it was either directly or indirectly related to the replication 
of SV40 DNA which was occurring at this time. In order to test his hypothesis we 
determined the effect of the inhibition of replication on the introduction of methylated 
H3K4 and H3K9. SV40 minichromosomes were prepared at 24 h post-infection when 
replication was beginning and at 48 h post-infection in the presence or absence of 
aphidicolin, a specific inhibitor of eukaryotic DNA replication (68). SV40 
minichromosomes were then subjected to ChIP analysis with antibodies to methylated 
H3K4 and H3K9. We first investigated the introduction of methylated H3 during the 
increase in SV40 chromatin resulting from replication between 24 and 48 h post-
infection. Since we generally observe a 50- to 200-fold increase in the pool size of SV40 
minichromosomes between 24 and 48 h post-infection, we compared the increase in a 
particular form of modification to the increase in the amount of SV40 minichromosomes. 
We expected that this ratio would be 1 if both the SV40 minichromosomes and form of 
modification were increasing at the same rate, greater than 1 if the newly replicated 
minichromosomes were more likely to contain the form of modification, or less than 1 if 
the minichromosomes were increasing faster than the introduction of the modified 
histone H3. The results of this analysis are graphically represented in Figure 7A. Based 
upon the observed ratios, all methylated forms of H3K4 and H3K9 were being introduced 
into the newly replicated minichromosomes at a rate faster than the increase in SV40 
chromatin. However, H3K4me2 and H3K9me3 appeared to be introduced at rates close 
to the rate of increase of chromatin (1.74 and 1.23, respectively), while the other 





Two copies of Site I directs the incorporation of more H3K9me1 compared to one copy 
of Site I in SV40 minichromosomes isolated at 48 h post-infection but not at 8 h post-
infection. SV40 minichromosomes were prepared from cells infected with pBM129-1 
(one copy of Site 1) or pBM131-1 (two copies of Site 1) at 8 and 48 h post-infection. The 
percentage of SV40 minichromosomes containing H3K9me1 was determined by ChIP 
analyses for each preparation of minichromosomes at each time point followed by real-
time PCR. The results are displayed as the ratio of the percentage of minichromosomes 
containing two copies of Site I immunoprecipitated by antibody to H3K9me1 over the 
corresponding percentage for minichromosomes containing one copy of Site I. A 
schematic of the structure of the SV40 recombinants pBM129-1 is shown in (A) and 
pBM131-1 in (B). pBM131-1 contains a second copy of Site I introduced into the 
reporter region of the basic recombinant, pBM 129-1. The results of this analysis are 
shown in (C). All analyses were performed a minimum of three times using different 






 Next, we determined whether the introduction of a particular form of methylated 
H3 was actually dependent upon ongoing DNA replication. If ongoing DNA replication 
was necessary for the introduction of a particular methylated form of H3, inhibition of 
replication with aphidicolin should also block the introduction of the methylated form of 
H3. In contrast if the introduction of a methylated form of H3 was due to some other 
biological process, one would expect little if any effect on the introduction of the 
methylated form of H3 following inhibition of replication. SV40 minichromosomes were 
isolated from cells treated with aphidicolin from 24 to 48 h post-infection or from 
untreated cells at 48 h post-infection and subjected to ChIP analysis and real-time PCR. 
For each methylated form of H3, we then calculated the ratio of the decrease in 
methylated H3 to the decrease in the amount of SV40 minichromosomes following 
inhibition of replication. A ratio of 1 or greater would indicate that the introduction of 
methylated H3 was equal to or even greater than the reduction in the amount of SV40 
chromatin, while a ratio near 0 would indicate that the introduction of methylated H3 was 
independent of DNA replication. The results of this analysis are graphically represented 
in Figure 7B. As shown in the figure the ratios for H3K9me1 (1.75) and H3K4me1 (0.92) 
were similar to or greater than 1 indicating that the introduction of these two methylated 
forms of H3 into SV40 chromatin were directly dependent upon DNA replication. The 
ratios for three of the methylated forms of H3 were very low including H3K4me2 (0.15), 
H3K4me3 (0.10), and H3K9me3 (0.17) indicating that these methylated forms of H3 
were being introduced in the absence of direct DNA replication. The ratio for H3K9me2 
(0.47) was intermediate between the other forms of methylated H3 suggesting that it was 







H3K4me1 and H3K9me1 are introduced into wild-type SV40 minichromosomes 
primarily during active replication. Wild-type SV40 minichromosomes were isolated at 
24, 48, and 48 h post-infection following treatment with the DNA replication inhibitor 
aphidicolin from 24 to 48 h post-infection. The percentages of SV40 minichromosomes 
containing methylated H3K4 and H3K9 were determined by ChIP analyses followed by 
real-time PCR. The relative increase of each methylated form of H3K4 and H3K9 
following DNA replication from 24 h to 48 h post-infection is shown in (A). The relative 
increase is shown as the ratio of the fold increase of a particular form of methylated H3 
between 24 and 48 h post-infection divided by the corresponding fold increase in the 
amount of SV40 minichromosomes between these times. Ratios greater than 1 indicate 
that a particular methylated form of H3 is preferentially being introduced into newly 
replicated minichromosomes at a rate faster than the increase in the pool size of SV40 
minichromosomes. The effects of the inhibition of DNA replication from 24 to 48 h post-
infection on the introduction of methylated H3K4 and H3K9 are shown in (B). The 
results are shown as the ratio of the fold decrease in the amount of a particular form of 
methylated H3 in minichromosomes following inhibition of DNA replication divided by 
the fold decrease in minichromosomes resulting from inhibition of replication. Ratios less 
than or equal to 1 indicate that a particular methylated form of H3 is inhibited to a greater 
or the same extent as the inhibition of replication of the total SV40 minichromosomes. 





While we believe that the changes observed following aphidicolin treatment are primarily 
a result of the extensive inhibition of replication, we cannot exclude the possibility that 
indirect effects on transcription or induction of the DNA damage response following 
aphidicolin might also be contributing to changes in histone modifications. 
 
Discussion 
In SV40 minichromosomes, repression of early gene expression by T-antigen 
binding to Site I in the viral regulatory region was shown to result in distinct epigenetic 
marks at early and late times post-infection. At early times when only early transcription 
was occurring T-antigen binding resulted in the inhibition of the introduction of 
H3K9me2, while at late times when replication was occurring T-antigen binding resulted 
in the introduction of H3K9me1. The latter was first shown in a previous publication 
(37). 
These results raise interesting questions concerning the mechanisms responsible 
for the introduction of epigenetic marks at the two time points in infection. Clearly, T-
antigen binding is required for the introduction of the majority of H3K9me1. However, 
T-antigen binding does not appear to be the only signal for the introduction of H3K9me1 
since a low level of H3K9me1 is still present in SV40 minichromosomes in a mutant in 
which T-antigen binding cannot occur. While Site I is necessary for the late introduction 
of H3K9me1, the Site I does not have to be located in the regulatory region since a 
recombinant containing an extra copy of Site I near the terminus of transcription showed 
an increase in H3K9me1 at late times but not early times. The location independent 
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increase in H3K9me1 in this recombinant suggests that Site I may be functioning like an 
enhancer to direct epigenetic changes (38). 
It seems likely that the T-antigen directed introduction of H3K9me1 is 
mechanistically related to DNA replication. First, we have previously shown that at late 
times in infection H3K9me1 was specifically associated with SV40 minichromosomes 
actively undergoing replication using a two-step ChIP protocol (39) in which actively 
replicating minichromosomes were immunologically selected for subsequent analysis 
using an antibody to RPA70 a replication protein (39). Second, this association was 
confirmed by characterizing SV40 chromatin following inhibition of replication by 
aphidicolin. H3K9me1 appeared to be directly related to replication since it increased 
when replication occurred and was completely blocked when replication was blocked. 
Although H3K4me1 also appeared to be a direct result of replication the other methylated 
forms of H3K4 and H3K9 appeared to result from post-replication maturation. The 
introduction of H3K9me3 following replication has been shown in HeLa cells to occur 
via a maturation process in which the H3K9me3 is introduced into previously replicated 
chromatin containing H3K9me1 (40). It is not clear how the binding of T-antigen to Site I 
at early times results in the inhibition of the incorporation of H3K9me2. Potentially T-
antigen might be disrupting the normal biological pathways linking H3K9me1 to 
H3K9me2 and H3K9me3. 
These results are not consistent with a model of chromatin replication in which 
the pre-existing histone modifications present in the parental chromatin are duplicated in 
the daughter chromatin during replication (64)(65). Instead these results suggest that in 
SV40 minichromosomes DNA replication can serve as an epigenetic switch in which 
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newly replicated chromatin can be epigenetically modified in response to specific signals 
such as T-antigen binding to Site I. It seems unlikely that the H3K9me1 present during 
replication is simply a consequence of H3K9me1 being present in parental chromatin. If 
this were the case one would expect similar levels of H3K9me1 in both the cs1085 
mutant and the wild-type virus since both contain H3K9me1 at early times. Secondly, a 
model in which pre-existing H3K9me1 drives the introduction of H3K9me1 following 
replication does not fit with the data obtained with the recombinant containing an extra 
copy of Site I. At early times the recombinant and its parental strain both contain similar 
levels of H3K9me1 yet at late times there is a significant increase in the amount of 
H3K9me1 present in replicated minichromosomes. This epigenetic switching hypothesis 
is consistent with a recent publication showing that replication of Drosophila chromatin 
occurs through a process in which pre-existing histone modifications are lost at the 
replication fork and histone modifications are re-introduced following replication by 
modifying complexes which remain closely associated with the replicating chromatin 
(69). The results differ in that in the publication pre-existing modifying complexes are 
thought to drive the introduction of post-replicative histone modifications while in SV40 
the post-replicative changes are driven by the binding of the repressive factor T-antigen. 
The most likely reason for the epigenetic switch is to ensure that newly replicated 
minichromosomes are not capable of activation for early transcription at late times in 
infection. Allowing activation of early transcription as in the case of the mutant cs1085 
has been shown to result in a significant reduction in the pool size of SV40 
minichromosomes and yield of virus late in infection (37). This epigenetic switch may 
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also play a critical role in controlling the relative pool sizes of transcribing, replicating, 
and encapsidating SV40 minichromosomes. 
While an epigenetic switch associated with replication appears to have a 
biological relevance for SV40 it is not yet clear whether a similar process functions in 
cellular chromatin. However, it is interesting to speculate that a similar process could act 
during cellular differentiation to prepare newly replicated chromatin for subsequent 
activation or repression of transcription in response to specific signals introduced during 
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We have recently shown that T-antigen binding to Site I results in the replication-
dependent introduction of H3K9me1 into SV40 chromatin late in infection. Since 
H3K9me2 and H3K9me3 are also present late in infection, we determined whether their 
presence was also related to the status of ongoing transcription and replication. 
Transcription was either inhibited with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole 
(DRB) or stimulated with sodium butyrate and the effects on histone modifications early 
and late in infection determined. The role of DNA replication was determined by 





 We observed that H3K9me2/me3 was specifically introduced when transcription 
was inhibited during active replication. The introduction of H3K9me2/me3 that occurred 
when transcription was inhibited was partially blocked when replication was also 
inhibited. The introduction of H3K9me2/me3 did not require the presence of H3K9me1 
since similar results were obtained with the mutant cs1085 whose chromatin contains 
very little H3K9me1. 
 
Conclusions 
Our data suggest that methylation of H3K9 can occur either as a consequence of a 
specific repressive event such as T-antigen binding to Site I or as a result of a general 
repression of transcription in the presence of active replication. The results suggest that 
the nonproductive generation of transcription complexes as occurs following DRB 
treatment may be recognized by a ‘proof reading’ mechanism, which leads to the specific 
introduction of H3K9me2 and H3K9me3. 
 
Background 
Five distinct but potentially related elements are thought to contribute to the 
epigenetic regulation of eukaryotic gene expression: DNA methylation, nucleosome 
location, histone variation, covalent histone modifications, and interactions by regulatory 
RNA. Of these elements, the post-translational modification of histones has been of 
particular interest because of the diversity of the available forms of modification and the 
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number of target amino acids and their physical location within histones. Importantly, 
there is an abundance of published reports demonstrating the association between certain 
forms of histone modification and activation or repression of transcription in one or more 
well characterized biological systems. 
In general, it is thought that acetylation of certain lysines in histones is associated 
with active biological processes like transcription while methylation of lysines or 
arginines may be associated with either activation or repression of gene transcription. For 
example, in the nucleosome core, histone H3 acetylation on lysine 9 and 14 (H3K9 and 
H3K14) have been shown to be associated with transcription along with methylation of 
lysine 4 (H3K4), while methylation of lysine 9 (H3K9) has been shown to be associated 
with repression (70)(71). 
While the association between the methylation of H3K9 and gene repression has 
been well established, much less is known about the circumstances that lead to the 
introduction of methylated H3K9 into chromatin. What has added to this uncertainty is 
the complexity of methylation, including mono-, di-, and tri-methylation, and the 
involvement of multiple methylating enzymes (72). 
In order to better understand the factors that contribute to epigenetic regulation, 
we have been investigating the role of histone modifications in the regulation of gene 
expression during the Simian Virus 40 (SV40) life cycle (52)(13)(53)(37)(73)(74). In a 
recent publication we confirmed that the mono-methylation of H3K9 in SV40 chromatin 
was associated with repression of transcription (74). Specifically, we showed that the 
introduction of H3K9me1 was a consequence of the repression of early transcription by 
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the product of transcription, T-antigen, binding to a critical regulatory sequence known as 
Site I (74). Moreover, importantly, we observed that the introduction of H3K9me1 during 
repression required DNA replication. Repression occurring prior to the initiation of 
replication was not associated with the introduction of H3K9me1. Our results 
demonstrated that replication could serve as an epigenetic switch and that the same 
biological event could have different epigenetic readouts depending upon whether 
replication was occurring. 
During the course of these studies, we investigated the introduction of all three 
methylated forms of H3K9 during replication. We noted that unlike the introduction of 
H3K9me1 which absolutely required replication, the introduction of H3K9me2 and 
H3K9me3 appeared to occur even when replication was substantially blocked by 
inhibitor (74). These results raised two important questions. First, was the introduction of 
H3K9me2 and H3K9me3 also associated with the repression of transcription in SV40 
chromatin, and second, what biological factors contributed to the introduction of these 
epigenetic marks? 
In order to address these questions in SV40 chromatin, we have investigated the 
effects of a general inhibition or stimulation of transcription on the introduction of H3K9 
methylation in the presence or absence of active replication. Transcription was inhibited 
with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB) (75), a well-characterized 
inhibitor of RNA Polymerase II (RNAPII) elongation, and stimulated with sodium 
butyrate, an inhibitor of histone deacetylase (76)(77) known to stimulate gene expression. 
DNA replication was inhibited with aphidicolin (68). We show that the introduction of 
H3K9me2 and H3K9me3 are the result of a general inhibition of transcription at late 
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times in infection but not early times, and that the introduction is partially dependent 
upon replication but not the prior introduction of H3K9me1. 
 
Results 
Inhibition of Transcription by DRB Stimulates the Introduction of H3K9me2 and 
H3K9me3 into SV40 Chromatin Late in Infection but not Early in Infection 
Since we previously observed that the introduction of H3K9me2 and H3K9me3 
was not directly related to repression by T-antigen binding to Site I (74) we hypothesized 
that their incorporation into SV40 chromatin might be the consequence of a more general 
inhibition of transcription. In order to test this hypothesis we determined the epigenetic 
consequences of inhibiting transcription with the RNAPII elongation inhibitor 5,6-
dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB). We have previously used DRB to 
investigate the relationship between RNA polymerase II translocation and the acetylation 
and deacetylation of histones during transcription (13). For these studies, we chose to 
investigate SV40 chromatin isolated at 2 hours post-infection when early transcription 
was occurring but prior to DNA replication, and at 48 hours post-infection when early 
and late transcription were occurring along with active replication. 
SV40 minichromosomes were isolated and purified from cells infected with wild-
type 776 virus following treatment with DRB or no treatment. When minichromosomes 
were isolated at 2 hours, cells were pretreated with DRB for 2 hours prior to infection, 
while for minichromosomes isolated at 48 hours post-infection infected cells were treated 
from 24 to 48 hours. In these experiments, we observed a 112 ± 35 fold increase in the 
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size of the pool of SV40 chromosomes present in glycerol gradient fractions following 
purification from cells infected for 48 hours compared to 24 hours post-infection. While 
the increase was somewhat variable we always observed at least a tenfold increase. This 
increase was reduced 10 ± 6 fold following treatment of the SV40 infected cells with 
DRB from 24 to 48 hours post-infection. The latter analysis was determined by 
comparing the increase in the presence and absence of inhibitor and indicates that on 
average there was about a tenfold reduction in the pool of SV40 minichromosomes 
following inhibition. As expected, treatment with DRB substantially inhibited the 
generation of mRNA (data not shown).The effect of DRB on the introduction of 
methylated H3K4 and H3K9 was determined by subjecting treated and untreated samples 
of intact SV40 minichromosomes obtained at 2 hours and 48 hours post-infection to ChIP 
analyses with antibodies that recognize mono-, di-, or tri-methylated H3K4 or H3K9. 
Intact SV40 minichromosomes were used because they are easily obtained in relatively 
large amounts and yield the maximum PCR signal compared to fragmented chromatin. 
Because the SV40 genome was intact, this analysis only yielded information relative to 
changes in the numbers of minichromosomes carrying a particular modification following 
treatment. No information was obtained concerning the location of any specific histone 
modifications. The results of these analyses are graphically shown in Figure 8. The data 
is displayed as the ratio of the percentage of minichromosomes that contain a 
modification following treatment divided by the percentage of untreated 
minichromosomes containing the same modification. If treatment had no effect on the 
introduction of a particular modification the ratio will be one. Ratios greater than one 
indicate that treatment results in an increase in the minichromosomes containing the 
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modification while ratios less than one indicate that treatment resulted in a decrease in the 
presence of a modification, As shown in Figure  8A and 8B, DRB treatment had no 
significant effect on the methylation of H3K4 at either 2 hours or 48 hours post-infection. 
For each form of methylation, the ratio of treated sample to untreated sample was 
approximately one. In contrast, DRB treatment had a significant effect on the presence of 
H3K9me2 and H3K9me3 at 48 hours post-infection and little effect at 2 hours post-
infection (Figure  5A and B). We observed a 6 ± 4 fold increase for H3K9me2 with a 
range from 3 to 12 for four independent samples and a 6 ± 2 fold increase for H3K9me3 
with a range of 3 to 8 for four independent samples. As expected from our previous 
published work, DRB treatment had no significant effect on the presence of H3K9me1 at 
either time point. 
 
Introduction of H3K9me2 and H3K9me3 Following Inhibition of Transcription is 
Partially Dependent Upon Replication 
 Since we have previously shown that the introduction of H3K9me2 and 
H3K9me3 into SV40 chromatin late in infection does not require DNA replication (88), 
we next tested whether replication played a role in the enhanced introduction of these 
modifications following DRB inhibition of transcription. SV40 minichromosomes were 
obtained from infected cells that were untreated or treated from 24 to 48 hours post-
infection with a combination of DRB and aphidicolin to inhibit both transcription and 
replication. The minichromosomes were then subjected to ChIP analyses with antibody to 





Inhibition of transcription with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB) 
stimulates the incorporation of H3K9me2 and H3K9me3 into SV40 chromatin late in 
infection. Wild-type SV40 minichromosomes were isolated at 2 hr post-infection with or 
without incubation with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB) from 
minus 2 hr until isolation and at 48 hr post-infection with or without incubation with 
DRB from 24 to 48 hr post-infection. The percentages of intact minichromosomes 
containing methylated H3K4 and H3K9 were determined by ChIP analyses followed by 
purification of the intact genomic DNA and PCR amplification with primers recognizing 
the promoter region. For each form of histone modification, the ratio of the percentage 
present in the treated minichromosomes compared to the untreated minichromosomes 
was calculated. The effects of DRB treatment on the introduction of methylated H3K4 
and H3K9 from minus 2 hr to isolation at 2 hr post-infection is shown in (A). The 
corresponding effects of DRB treatment on the introduction of methylated H3K4 and 











the ratio between the percentages of input minichromosomes containing the modification 
of interest in the treated sample compared to the untreated sample.  
Treatment with aphidicolin and DRB resulted in approximately a 99% reduction 
in the amount of SV40 minichromsomes obtained at 48 hours post-infection compared to 
the amount obtained from untreated cells. Following inhibition we observed no increases 
in the ratio for H3K9me2 (1 ± 0.5) and a small increase in the ratio for H3K9me3 (2 ± 1). 
These increases were significantly lower than the values obtained when transcription was 
inhibited while DNA replication was occurring as shown in Figure 8. These results 
suggest that ongoing replication plays at least a small role in the introduction of 
H3K9me2 and H3K9me3 at late times in infection. 
 
Introduction of H3K9me2 and H3K9me3 Following Inhibition of Transcription does not 
Require the Presence of H3K9me1 
Since H3K9me1 can be present in as much as 22% of the SV40 
minichromosomes present at late times (37), it seemed reasonable that the H3K9me1 
containing minichromosomes might serve as substrates for the introduction of H3K9me2 
and H3K9me3. To test this possibility we characterized the effect of DRB treatment on 
the mutant cs1085 SV40 virus. This mutant lacks T-antigen binding Site I and as a 
consequence fails to down-regulate early transcription. We have previously shown that 
minichromosomes from this mutant contain very low levels of H3K9me1in contrast to 
parental wild-type viral chromatin (37). If the minichromosomes containing H3K9me1 





The 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB)- stimulated introduction of 
H3K9me2 and H3K9me3 is partially dependent upon ongoing DNA Replication. Wild-
type SV40 minichromosomes were isolated at 48 hr post-infection with or without 
treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB) and aphidicolin 
from 24 to 48 hr post-infection. The treated and untreated intact minichromosomes were 
subjected to ChIP analyses with antibodies to H3K9me2 and H3K9me3 and the 
percentages of the minichromosomes containing the modified H3K9s determined by real-
time PCR amplification of the bound intact SV40 genomic DNA with primers 
recognizing the promoter region. The fold increase in the percentages of 









we would expect that inhibition of transcription of cs1085 with DRB would not result in 
a large increase in the amounts of H3K9me2 and H3K9me3 in the treated 
minichromosomes compared to the untreated minichromosomes. Cells infected with 
SV40 cs1085 virus were treated with DRB from 24 to 48 hours post-infection or left 
untreated and the minichromosomes present in the cells isolated and purified. The 
minichromosomes were subjected to ChIP analyses with antibodies to H3K9me2 and 
H3K9me3 with the results shown in Figure 10. Treatment with DRB resulted in 
significant increases in the amounts of H3K9me2 (3 ± 1 fold) and H3K9me3 (5 ± 3 fold) 
present in the cs1085 minichromosomes indicating that the presence of H3K9me1 in the 
minichromosomes was not necessary for the introduction of the higher levels of 
methylated H3K9. 
 
Introduction of H3K9me2 and H3K9me3 are Associated with SV40 Minichromosomes 
that Contain RNAPII 
In order to determine whether H3K9me2 and H3K9me3 were being added to 
minichromosomes that contain RNAPII following treatment with DRB, we analyzed 
SV40 minichromosomes that contain RNAPII for the presence of the two methylated 
forms of H3K9 following treatment with DRB using our ISFIP procedure (52)(73). In 
this procedure, SV40 minichromosomes containing RNAPII were immune-selected with 
antibody to RNAPII bound to protein A agarose in a standard ChIP assay. Following 
purification of the bound chromatin and prior to elution, the minichromosomes bound to 





The 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB)- stimulated introduction of 
H3K9me2 and H3K9me3 does not require the presence of H3K9me1. SV40 
minichromosomes from the mutant virus cs1085 were isolated at 48 hr post-infection 
with or without treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB) 
from 24 to 48 hr post-infection. Intact minichromosomes were subjected to ChIP analyses 
with antibody recognizing H3K9me2 and H3K9me3 and the intact SV40 genomic DNA 
present in the bound fraction quantitated by real-time PCR with primers recognizing the 
promoter region. The percentages of minichromosomes in the treated and untreated 
samples were determined and the fold increase in the percentage in the treated samples 




bound fragments separated from the released fragments. The released fragments were 
then subjected to a second ChIP with antibodies to H3K9me2 and H3K9me3 to 
determine whether H3K9me2 and H3K9me3 were present in the minichromosomes 
containing RNAPII and if so whether the amount changed upon treatment with DRB. As 
shown in Figure 11 we observed increases in the percentage of the RNAPII containing 
minichromosomes which also contained H3K9me (2 ± 1 fold) and H3K9me3 (3 ± 2 fold) 
although not as significant as those observed in Figure 8. These results suggest that 
minichromosomes containing RNAPII may serve as the substrate for H3K9 methylation. 
 
Stimulation of Transcription with Sodium Butyrate Inhibits the Incorporation of 
H3K9me2 and H3K9me3 into SV40 Chromatin Late in Infection 
 Since the introduction of H3K9me2 and H3K9me3 appeared to be associated with 
repression of transcription, we then determined whether stimulation of transcription 
would have the opposite effect. Sodium butyrate is a well-known inhibitor of many 
histone deacetylases and for this reason has been used extensively to investigate the 
relationship between histone acetylation and various biological processes including 
transcription (76)(77). We have previously shown that inhibition of histone deacetylases 
by sodium butyrate results in an increase in transcription of actively transcribed genes as 
well as an increase in histone acetylation (53)(78). If increased transcription and/or 
histone acetylation prevented the introduction of H3K9me2 or H3K9me3, we would 
expect to see a reduction in the ratio of these two modified forms of H3 in the treated 
minichromosomes compared to the untreated minichromosomes. 
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SV40 wild-type infected cells were harvested at 24 hours post-infection, 48 hours 
post-infection, or 48 hours post-infection following treatment with 50 μM sodium 
butyrate from 24 to 48 hours post-infection to determine the effects of sodium butyrate 
during the period of active replication. In a parallel analysis, infected cells were harvested 
at 12 hours post-infection and 12 hours following a 12-hour treatment with sodium 
butyrate to determine the effects of sodium butyrate in the absence of replication. The 
minichromosomes were purified and subjected to ChIP analyses with antibodies to 
methylated H3K4 and H3K9 with minichromosomes isolated late in infection but only 
methylated H3K9 when isolated at very early times. The reason for this was our previous 
observation that relatively little of the SV40 chromatin contained methylated H3K4 at the 
very early times (37) and because there was no change in the levels of methylated H3K4 
following DRB treatment. As shown in Figure 12, we observed ratios close to 1 for 
H3K9me1 (0.9 ± 0.1) and H3K9me3 (1.5 ± 0.8) in minichromosomes isolated at 12 hours 
post-infection. We saw very low levels of H3K9me2 in both treated and untreated 
minichromosomes, which were too variable to quantitate at this time. In contrast, for 
minichromosomes isolated at 48 hours post-infection, we observed significant inhibition 
of H3K9 methylation. The ratios were 0.46 ± 0.13 for H3K9me1, 0.08 ± 0.04 for 
H3K9me2, and 0.39 ± 0.2 for H3K9me3. While H3K4me2 (0.75 ± 0.13) and H3K4me3 
(1.26 ± 0.38) did not seem to be affected by sodium butyrate treatment at late times, 
H3K4me1 (0.47 ± 0.27) appeared to be moderately inhibited (data not show). The 
decrease in the levels of H3K9me2 and H3K9me3 when transcription was stimulated 
were consistent with the idea that these modifications were being introduced as a 





The 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB)- stimulated introduction of 
H3K9me2 and H3K9me3 is partially associated with minichromosomes containing 
RNAPII. Wild-type SV40 minichromosomes were isolated from cells at 48 hr post-
infection with or without treatment with 5,6-dichloro-1-beta-D-
ribofuranosylbenzimidizole (DRB) from 24 to 48 hr post-infection. Intact 
Minichromosomes were subjected to an ISFIP ChIP analysis in which minichromosomes 
were first immune selected with antibody to RNAPII. The minichromosomes bound by 
antibody to RNAPII were sonicated and the soluble chromatin fraction subjected to a 
second ChIP with antibody to either H3K9me2 or H3K9me3. The percentage of the 
treated and untreated chromatin containing H3K9me2 and H3K9me3 was determined by 
real-time PCR using primers that recognize the early region of the genome and the fold 












The introduction of H3K9me2 and H3K9me3 is inhibited by sodium butyrate stimulation 
of transcription during active replication. Wild-type SV40 minichromosomes were 
isolated at 12 hr post-infection with or without treatment from the initiation of infection 
with sodium butyrate and at 48 hr post-infection with or without treatment with sodium 
butyrate from 24 to 48 hr post-infection. Intact minichromosomes isolated at 12 hr post-
infection were subjected to ChIP analyses with antibodies to methylated H3K9. Intact 
minichromosomes isolated at 48 h post-infection were subjected to ChIP analyses with 
antibodies to methylated H3K4 and methylated H3K9. The percentage of treated and 
untreated minichromosomes containing each form of methylated H3K4 or H3K9 was 
determined by real-time PCR amplification of the intact SV40 genomic DNA with 
primers recognizing the promoter region. The fold change resulting from treatment was 





Pools of transcribing SV40 minichromosomes are Dynamic During Replication 
Since DRB had a major effect on transcription and the introduction of H3K9me2 
and H3K9me3, we also determined whether it affected the proportion of 
minichromosomes carrying RNAPII and was, therefore, potentially capable of 
transcription. We have previously shown that with short-term treatment with DRB there 
was little effect on the percentage of minichromosomes carrying RNAPII (13). However, 
long-term treatment when replication was occurring could be different. In order to better 
understand the factors contributing to determining the pool size of minichromosomes 
containing RNAPII during this time frame, we also investigated the effects of aphidicolin 
and sodium butyrate. If the pool of minichromosomes containing RNAPII was simply 
related to the overall size of the pool of minichromosomes, we would expect to observe 
that the percentage containing RNAPII would remain constant despite the overall 
changes in the size of the pool following the different treatments. For this analysis, we 
compared the percentage of RNAPII containing minichromosomes at 24 hours post-
infection when replication was beginning to 48 hours post-infection when replication was 
active in the presence or absence of the replication inhibitor aphidicolin, transcription 
inhibitor DRB, or transcription stimulator sodium butyrate. 
As indicated above, between 24 and 48 hours post-infection we observed a 
112 ± 35 fold increase in the size of the minichromosome pool. Following treatment with 
aphidicolin the pool size at 48 hours post-infection was essentially the same as at 24 
hours post-infection indicating substantial inhibition by the drug. Following treatment 
with DRB we again observed a substantial increase in the pool of minichromosomes 
although the increase was 10 ± 6 fold less than observed in the absence of the inhibitor. 
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Treatment with sodium butyrate was seen to increase the size of the pool of 
minichromosomes by 10 ± 4 fold above the level of increase without the added sodium 
butyrate. The latter two results indicate that the inhibitors had a modest effect on pool 
sizes when replication was occurring.SV40 minichromosomes from treated or untreated 
infections were subjected to ChIP analysis with antibody to RNAPII with the results 
shown in Figure 13. We observed that the ratio of the percentage of minichromosomes 
containing RNAPII was only 0.14 ± 0.04 comparing minichromosomes isolated at 48 
hours post-infection to 24 hours post-infection indicating that only a small fraction of the 
newly replicated minichromosomes became associated with RNAPII. Following 
treatment with aphidicolin to block replication the ratio was reduced even further. 
Compared to untreated controls at 48 hours the ratio was 0.64 ± 0.16. Since there was no 
increase in the overall pool size this indicated that the actual amount of SV40 chromatin 
containing RNAPII following inhibition of replication was lower in the treated samples 
than was present at 24 hours post-infection. Following treatment with DRB from 24 to 48 
hours post-infection the ratio of minichromosomes containing RNAPII increased to 
1.2 ± 0.5, indicating that the pool size of transcribing minichromosomes was increasing 
along with replication in the presence of DRB. Finally, we observed that treatment with 
sodium butyrate during replication also had a profound effect. The ratio of RNAPII 
containing minichromosomes was 0.39 ± 0.20 following treatment with sodium butyrate 
from 24 to 48 hours post-infection. This indicated that compared to untreated controls a 







The pool size of SV40 minichromosomes containing RNAPII is dynamic and dependent 
upon replication and rate of transcription. SV40 minichromosomes were isolated from 
cells infected with wild-type virus at 24 and 48 hr post-infection. Infected cells were 
either untreated or treated from 24 to 48 hr post-infection with DRB, sodium butyrate 
(NaBt), or aphidicolin. Intact minichromosomes were subjected to ChIP analyses with 
antibody to RNAPII and the percentage of untreated and treated minichromosomes 
containing RNAPII was determined by real-time PCR amplification of the intact SV40 
genomic DNA with primers recognizing the promoter region. The fold increase or 
decrease from 24 to 48 hr post-infection with or without treatment was then calculated 






The introduction of H3K9me2 and H3K9me3 into SV40 chromatin following 
repression of transcription through the inhibition of RNAPII elongation by the inhibitor 
DRB is consistent with previous reports showing that the presence of H3K9me2 and 
H3K9me3 in chromatin is associated with transcriptional repression (reviewed in 
(79)(80)). H3K9me3, in particular, is now considered a characteristic mark of repression 
by many laboratories (71). 
H3K9me2 and H3K9me3 are typically introduced into chromatin by a member of 
the SET domain family of histone methyltransferases (80). The related proteins G9a and 
GLP are thought to be primarily responsible for H3K9me2 methylation in euchromatin, 
whereas Suv39H1 is thought to be responsible for H3K9me3 methylation in 
heterochromatin (31)(33)(32). G9a/GLP also appears to be capable of introducing 
H3K9me3 into euchromatin (81). While these proteins contribute to the bulk of the 
H3K9me2 and H3K9me3 in a cell, there are other methyltranferases that may also play a 
role since deletion of these enzymes cause a significant but not complete reduction in 
H3K9 methylation (80). 
There are two well-characterized mechanisms for the introduction of H3K9me2 
and H3K9me3. H3K9me2 is associated with repression of nuclear hormone receptor 
regulated transcription (reviewed in (79)). In this model system, the introduction of 
H3K9me2 is the consequence of the binding of the receptor along with the histone 
methyltransferase to maintain a repressive environment. Introduction of the ligand results 
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in the selective loss of the methyltranferase and subsequent corresponding loss of 
H3K9me2 and activation of transcription (79). 
The introduction of H3K9me3 into heterochromatin has also been extensively 
characterized (reviewed in (80)). The introduction of H3K9me3 in heterochromatin is 
thought to be closely linked with replication and to occur through the targeting of the 
relevant methyltranferase by associated proteins including CAF1, HP1, and MBD1 in 
higher eukaryotes (40)(82) and Clr4 and Swi6 in fission yeast (80). The presence of 
MBD1 in higher eukaryotes links H3K9me3 to DNA methylation and suggests a possible 
mechanism for targeting the complex to the appropriate sites (hemi-methylated DNA) 
following replication. 
It seems unlikely that either of these mechanisms is responsible for the 
introduction of H3K9me2 and H3K9me3 reported here. With respect to the introduction 
of H3K9me2, SV40 transcription does not appear to be regulated by a nuclear hormone 
type mechanism as previously described for H3K9me2. Similarly the observed increase 
in H3K9me2 occurred as a consequence of the inhibition of transcription by DRB not the 
binding of normal transcription factors. The introduction of H3K9me3 also is unlikely to 
occur by the same mechanism as described for heterochromatin. Notably, SV40 DNA in 
chromatin is not known to be methylated because of an absence of DNA methylase 
substrates in the DNA. Also our observed increase in H3K9me2 and H3K9me3 appeared 
to be only secondarily a result of DNA replication since the increase was observed on 
minichromosomes containing RNAPII. 
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To explain our results we propose the following model. As DNA replication takes 
place, some of the newly replicated minichromosomes are committed to transcription 
through the binding of specific and general transcription factors. Concurrently, for 
reasons as yet unknown, some of the preexisting transcribing minichromosomes stop 
transcription. These nonfunctioning minichromosomes are recognized as being repressed, 
and H3K9me2 and H3K9me3 are introduced into their chromatin as a mark of repression. 
We propose that following replication and the activation for new transcription there is a 
‘proofreading mechanism,’ which ensures that the newly initiated minichromosomes are 
capable of productive transcription. In the event that this is not the case, the 
minichromosomes are again recognized as repressed, as with the nonfunctioning 
minichromosomes, and marked by H3K9me2 and H3K9me3. Since treatment with the 
inhibitor DRB results in a large increase in the number of minichromosomes in which 
transcription is stopped, presumably at initiation, there is a corresponding increase in the 
incorporation of H3K9me2 and H3K9me3. 
This proofreading mechanism could be specific to SV40 and other similar viruses 
in which case it could function to ensure that the size of the pool of transcribing 
minichromosomes is tied to the level of replication and encapsidation. Conversely, this 
mechanism could be true for higher eukaryotes in general and serve as a way to ensure 
that when genes are activated for transcription, only those genes correctly activated are 
allowed to persist in the activated state. 
Assuming that the introduction of H3K9me2 and H3K9me3 following the 
inhibition of elongation by RNAPII reflects a normal biological process for SV40, we 
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believe it is likely to play a role in two aspects of normal SV40 molecular biology. First, 
the introduction of H3K9me2 and H3K9me3 could play a critical role in regulating the 
pool size of transcriptionally competent minichromosomes during an infection. We have 
presented evidence that the pool size is dynamic with new transcribing minichromosomes 
entering the pool as a result of replication and old minichromosomes leaving the pool. 
We believe that old minichromosomes leaving the pool of transcribing minichromosomes 
would be labeled with H3K9me2 and H3K9me3 in order to prevent their reactivation. 
Second, H3K9me2 and H3K9me3 could also play a critical role during the 
initiation of a subsequent infection. We have shown that minichromosomes in virions 
contain significant amounts of H3K9me2/3 (37). If the minichromosomes, which contain 
these modifications, result primarily from the minichromosomes that originally 
transcribed the late genes following replication, it seems desirable that they be silenced 
during a new infection when only the transcription of the early genes is required. 
Allowing transcription of the late genes during the establishment of an infection would 
seem to be very undesirable for the virus. 
Because DRB treatment blocks RNAPII elongation, we believe that it is a way to 
model the effects of repression of transcription in order to characterize the subsequent 
changes in epigenetic modifications. However, we recognize that the DRB treatment, as 
well as the treatment with the other inhibitors themselves, may be responsible for the 
observed effects on the levels of H3K9me2 and H3K9me3 and may not accurately reflect 




Methylation of H3K9 can occur during active expression either as a consequence 
of a specific repressive event such as T-antigen binding to Site I or as a result of a general 
repression of transcription. Moreover, these results suggest that the nonproductive 
transcription complexes which are generated by DRB treatment may be recognized by a 




Cells and Viruses 
Wild-type and mutant SV40 minichromosomes were prepared in the monkey 
kidney BSC-1 cell line (ATCC) using either wild-type 776 virus (from Dr. Daniel 
Nathans) or cs1085 virus (from Dr. Daniel Nathans). 
 
Cell Culture and Infections 
BSC-1 cells were maintained and infected as previously described [5–52]. An 
RNA polymerase II inhibitor, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB), 
was used at a concentration of 200 μM. For 2-hour infections, DRB was added two hours 
prior to infection and re-applied at 30 minutes post-infection when the media was 
replaced by fresh media without virus. For 48-hour infections, DRB was added at 24 
hours post-infection. Sodium butyrate was used at a concentration of 250 μM. Sodium 
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butyrate was added at infection and along with fresh media following removal of 
unbound virus for 12-hour infections and at 24 hours post-infection for 48-hour 
infections. Replication was inhibited with aphidicolin added at 24 hours post-infection at 
a final concentration of 6 μM as previously described (74). 
 
Preparation of SV40 Minichromosomes 
SV40 minichromosomes were isolated at the indicated times from 2 hours to 48 
hours post-infection as described for each of the analyses using our standard purification 
protocols with one minor modification. After transferring the lysed cells to a 15-ml 
centrifuge tube, an additional one ml of nuclei preparation buffer was used to rinse the 
flask and was subsequently added to the centrifuge tube in order to maximize the yield of 
minichromosomes from each infection. 
 
Chromatin Immunoprecipitation 
ChIP kits were obtained from Millipore (Temicula, California, USA) and the 
protocol was followed as previously described (74). The antibodies used included: 
H3K4me1 (07 = 436, Millipore (Temicula, California, USA), H3K4me2 (39141, Active 
Motif Carlsbad, California, USA), H3K4me3 (04 = 745, Millipore Temicula, California, 
USA), H3K9me1 (ab9045, Abcam, Cambridge Massachusetts USA), H3K9me2 (ab1220, 
Abcam, Cambridge, Massachusetts, USA), H3K9me3 (ab8898, Abcam, Cambridge, 
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Massachusetts, USA), and RNA PII 905 = 623, Millipore,Temicula, California, USA). 
All antibodies were ChIP validated by the respective vendors. A total of 100 μl of Protein 
A agarose, 800 μl chip dilution buffer, and 7.5 μl of each antibody were combined in a 
protein low-bind tube. The mixture was rotated for 5 hours at 4°C on an end to end 
rotator in a refrigerator to bind the antibody to Protein A agarose. Following binding of 
the antibody, the Protein A agarose was centrifuged at 2,000 rpms for 2 minutes and the 
supernatant discarded. Next, 800 μl of fresh ChIP dilution buffer was added, and 100 μl 
of the SV40 chromatin to be analyzed was added. The samples containing antibody 
bound to Protein A agarose and chromatin were incubated with end to end rotation for a 
further 7 hours at 4°C. The chromatin bound to Protein A agarose was washed according 
to the manufacturer’s protocol and eluted as previously described (74). 
 
Immune Selection Fragmentation Immunoprecipitation 
ChIPs were performed as previously described with the following changes. The 
amount of input chromatin added was increased to 200 μl and the amount of Protein A 
agarose was doubled to 200 μl. Following the final wash of the protein A agarose 
containing antibody and bound chromatin, the agarose was resuspended in 200 μl of 
buffer and transferred to a clean low-bind Eppendorf centrifuge tube. The suspension was 
sonicated using a Branson Digital Sonifier for 6 minutes with the amplitude set at 50%. 
The sonicated samples were centrifuged at 2,000 rpms for 2 minutes to separate the 
chromatin that remained bound to the agarose from the fragmented chromatin in the 
supernatant and the supernatant chromatin saved. The chromatin that remained bound to 
99 
 
agarose following sonication was removed with lysis buffer according to the ChIP kit’s 
instructions. The supernatant was then used as the starting material for a subsequent 
ChIP. 
Preparation of DNA: Samples were prepared for PCR using an MP Bioscience 
(Solon, Ohio, USA) Geneclean Spin Kit (#111101-200) with the following modifications. 
The glassmilk reagent (100 μl) was mixed with 50 μl of sample in a 1.5-ml centrifuge 
tube. The tube was mixed by repeated inversion at 2 minutes and again at 4 minutes of 
incubation. Following 5 minutes of room temperature incubation, the samples were 
centrifuged at 6,000 rpm for 30 seconds in a Micro One (Tomy) to pellet the glass. The 
supernatant was discarded and 200 μl of the wash buffer was added to the tube. As the 
wash buffer was being added, the pipette tip was used to break up the pellet by physically 
rubbing the pellet and vigorously pipetting up and down. The samples were inverted 
twice and centrifuged at 6,000 rpm for 30 seconds to again pellet the glass. The 
supernatant was discarded and the pellets were dried in a vacuum for 5 minutes. The 
glass pellet with bound DNA was resuspended in 25 μl Tris EDTA (TE) buffer. 
 
PCR Amplification 
For most of the amplifications, DNA was amplified from the promoter region of 
the SV40 genome using the primers 5′ TTG CAA AAG CCT CCA AA 3′ and 5′ TGA 
CCT ACG AAC CTT AAC CGA GGG 3′ in a CFX Connect Real Time System thermal 
cycler (Bio-Rad, Ipswich, Massachusetts, USA) using ‘SSO Advanced DNA polymerase 
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(Bio-Rad, Ipswich, Massachusetts, USA). In the immune selection fragmentation 
experiment, DNA was amplified from the early region using the primers 
5′TGCTCCCATTCATCAGTTCC3′ and 5′CTGACTTTGGAGGCTTCTGG3′ because 
the promoter region is extremely sensitive to sonication. Immediately before use, the 
primers and DNAse free water were added, and 28 μl of the mix was used per sample. 2 
μl of the resuspended glass milk in TE buffer was added per sample. Samples were 
amplified by PCR in triplicate with a melt curve applied afterwards to ensure specific 
amplification. All sample preparation for PCR was done in either a Nuaire biological 
safety cabinet Model NU_425-400 or an AirClean 600 PCR Workstation (ISC 
BioExpress). 
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DISCUSSION AND CONCLUSIONS 
 
Epigenetics Relating to Cancer and Disease States 
One critical function of an epigenome is its ability to vary itself depending on 
current cellular needs. These needs can be short turn, for example in the ability to 
respond to stressor events such as an elevated environmental temperature, or they can be 
long term, such as the ability to differentiate into different cell types in an organism. 
(83)(84) Many disease states and cancer types result in part from improper epigenetic 
regulation of these natural variations in an organism’s epigenome. In order to better 
understand how these illnesses result in part from disregulated epigenetic control more 
research is needed to understand the factors that go into properly regulated epigenetic 
control. 
 
Viral Epigenetics as a Eukaryotic Epigenetic Model 
Individual cells are understood to have a single epigenetic state in terminally 
differentiated cells that is passed on during replication. Inheritance of these epigenetic 
patterns is critical to properly maintain cell lineages and preserve cellular function. 
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Histone modifications have been identified as one of the ways chromatin maintains its 
epigenetic identity through the semi-conservative process of DNA replication. (39) One 
model is that the histones from the replicated chromatin are randomly deposited unto the 
newly formed chromatin strands. These conserved histones then promote the existing 
modifications onto newly incorporated histones. (65) 
While cellular chromatin in terminally differentiated cells is understood to have a 
single epigenetic state that is passed on during replication, this body of research shows 
that viral chromatin in the SV40 model system exists as multiple epigenetic states which 
vary throughout the lifecycle of the virus. These states are in a controlled and dynamic 
flux through the lifecycle of the virus, thus having replication function as an epigenetic 
switch is not supported by the theory of histones maintaining the epigenome of the 
parental strand of chromatin. The incorporation of new epigenetic patterns following 
replication as seen when using SV40 as a model system may parallel epigenetic 
mechanisms in differentiating cell lineages and more research should be done in this area. 
 
Mechanisms of SV40 Epigenetic Regulation 
 Our initial studies mapping the patterns of H3K4 and H3K9 led us to question 
whether the binding of T-antigen to site 1 results in an increase in the amount of 
H3K9me1 present on SV40 minichromosomes. When comparing WT SV40 to the two 
mutants CS1085 and SM, H3K9me1 was notably reduced at 48 hours in the CS1085 
(0.66±0.6%) mutant compared to wild type virus (22 ± 10%), whereas the SM mutant 
had increased incorporation of H3K9me1 (39 ± 9%) relative to wild type. This supports 
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the hypothesis that T-antigen binding results in the incorporation of H3K9me1, as 
CS1085’s inability to bind T-antigen resulted in a near absence of H3K9me1 contrasted 
by SM’s overproduction of T-antigen resulting in an increase of H3K9me1 at 48 hours.  
 As T-antigen is the agent responsible for the repression of early transcription we 
wanted to determine if the H3K9me1 patterns we saw at late times as a result of T-
antigen binding to Site 1 were similar at early times during repression of transcription. If 
H3K9me1 was related to the repression of early transcription we would see these levels 
become enriched during the 30 minute to 8 hour post infection time period. However, we 
instead saw a reduction of H3K9me1 during this time period which correlated to the 
reduction of RNAPII bound to minichromosomes. 
 Since this was an unexpected result we wanted to confirm that T-antigen binding 
to Site 1 was responsible for the H3K9me1 levels we documented, both the reduction at 8 
hours post infection and the enrichment at 48 hours post infection. A mutant with two 
Site 1’s was used to determine if T-Antigen binding to Site 1 had the effects on 
H3K9me1 incorporation. Confirming what we observed in earlier experiments, two 
copies of Site 1 resulted in a reduction of H3K9me1 at 8 hours post infection yet resulted 
in an enrichment of H3K9me1 at 48 hours post infection. 
 Replication was inhibited using aphidicolin in order to examine if the changes we 
were seeing between 8 hours and 48 hours post infection in H3K9me1 levels were due to 
T-antigen binding. Inhibition of replication resulted in the reduction of levels of 
H3K4me1 and H3K9me1, indicating a dependence of replication for the incorporation of 
these epigenetic marks. 
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 While investigating H3K9me1’s relationship to Site 1 and replication, 
incorporation of H3K9me2 and H3K9me3 were shown to be independent of replication.  
In order to determine if inhibition of transcription was related to the incorporation of 
H3K9me2 and H3K9me3, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidizole (DRB) was 
used to inhibit transcription at both the 2 hour time point and at the 48 hour time point. 
Inhibition of transcription by DRB had little effect on H3K4 methylation at any time 
point measured.  H3K9me1 levels also experienced little change at the 2 hour time point 
measured. However, at the 48 hour time point we observed a 6 ± 4 fold increase for 
H3K9me2 with a range from 3 to 12 for four independent samples and a 6 ± 2 fold 
increase for H3K9me3 with a range of 3 to 8 for four independent samples. 
 To further characterize the differences we were seeing at 2 hours compared to 48 
hours in the presence and absence of transcriptional inhibition by DRB in H3K9me2 and 
H3K9me3, replication was inhibited in conjunction with transcription. These results were 
significantly lower than previously seen with DRB inhibition alone, suggesting that 
replication plays a role in the introduction of H3K9me2 and H3K9me3 at late times in 
infection. 
Finally, to determine if repression of transcription was causing the changes in 
H3K9me2 and H3K9me3 that we documented, transcription was stimulated to determine 
if increased transcription had the opposite effect. We observed ratios close to 1 for 
H3K9me1 (0.9 ± 0.1) and H3K9me3 (1.5 ± 0.8) in minichromosomes isolated at 12 hours 
post-infection. We saw very low levels of H3K9me2 in both treated and untreated 
minichromosomes, which were too variable to quantitate at this time. In contrast, for 
minichromosomes isolated at 48 hours post-infection, we observed significant inhibition 
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of H3K9 methylation. The ratios were 0.46 ± 0.13 for H3K9me1, 0.08 ± 0.04 for 
H3K9me2, and 0.39 ± 0.2 for H3K9me3. This is consistent with the idea that these 
modifications were being introduced as a consequence of a general repression of 
transcription at late times. 
 The results presented here are inconsistent with the model of chromosomal 
replication where preexisting histone modifications contained on that parental 
chromosome are duplicated on the newly replicated daughter chromosome. (64)(65)  
These results point to a model in which replication acts as an epigenetic switch resulting 
in newly replicated chromatin responding to the binding of T-antigen to Site 1 and 
incorporating a specific epigenetic pattern.  In SV40 evidence suggests newly replicated 
chromosomes are not directed to specific fates as a result of the parental chromosome due 
to the differences in H3K9me1 levels in CS1085 from 30 minutes to 8 hours compared to 
wild-type infections.  Also, the recombinant with two copies of Site 1 present is 
inconsistent with the model of preexisting histone modifications driving duplication in 
daughter chromosomes following replication.  The model supporting an epigenetic switch 
would occur through losing current histone modifications at the replication fork and new 
histones are modified following replication by histone modifying complexes associated 
with the replication fork. (69)  This model allows for signals, such as T-antigen, to 
modulate post-replicative modifications on histones. 
 One biological benefit for possessing an epigenetic switch as our model suggests 
would be to control newly replicated chromosomes and direct their biological fate.  For 
example, at late times in infection the virus would benefit from not producing 
chromosomes which would undergo early transcription, but rather would benefit from 
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chromosomes primed for encapsidation.  An example of this can be seen in the CS1085 
mutant which has over-expression of early transcription and thus a greatly reduced yield 
of genetic material at 48 hours post-infection. (37)  It is likely that incorporation of 
H3K9me1 methylation, which is known to be repressive for transcription in SV40, helps 
prevent newly replicated chromosomes generated late in infection from undergoing active 
early transcription. 
SV40 as a Model for a Proofreading Mechanism to Silence Unproductive Chromosomes 
 This is a proposed model to support this data.  After DNA is replicated a portion 
of the replicated chromosomes initiate transcription.  A portion of these newly replicated 
and transcribing chromosomes have their RNAPII halted.  These halted chromosomes are 
detected and marked with H3K9me2 and H3K9me3 as part of a currently unidentified 
proof reading mechanism that can detect chromosomes which are unable to function in a 
productive manner.  Treatment with DRB supports this model as it results in a large 
portion of chromosomes with halted RNAPII which become detected by this proof 
reading mechanism which silence the chromosomes preventing further transcription by 








Epigenetic Progression of SV40 Lifecyle 
 This research shows the existence of distinct epigenetic patterns on incoming 
virions, chromatin at early time points in infection, and chromatin at 48 hours post 
infection. One finding that makes the research presented here unique is evidence for the 
existence of at least 5 different SV40 epigenomes present at 48 hour point infection. One 
consisted primarily of H3K4me2 in conjunction with H3K9me1, H3K9me2, H3K9me3, 
and hyperacetylated H4 (HH4). A second form also consisted primarily of H3K4me2 but 
in conjunction with HH3 and HH4. This conclusion was based upon the fact that H3K9 
cannot be methylated and acetylated at the same time, which we experimentally 
confirmed. A third epigenome consisted almost solely of H3K4me3 with some HH4 also 
present. The fourth epigenome consisted of H3K9me1 along with H3K9me2, H4K20me1 
and HH4. The fifth epigenome consisted primarily of H3K9me3 with trace amounts of 
other modifications. 
 As discussed in chapter 5, while this is the first demonstration that multiple 
distinct viral epigenomes defined by specific combinations of histone modifications are 
present in infected cells, the co-localized modified histones are in agreement with 
previously reported results for cellular chromatin. For example, H3K9me1 has been 
previously shown to be co-localized within nucleosomes of transcribing regions with 
H3K4me1/2/3, H3K79me1/2/3 and H4K20me1 using a genome-wide strategy. H3K9me3 
was found associated with H3K9me2 and H3K27me2/3 in silenced regions. 
 Mnichromosomes have different functions throughout the course of the viral 
lifecycle. Incoming virion particles need to be transported into the nucleus to initiate 
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early transcription. Once the early viral proteins have repurposed the cellular machinery, 
T-antigen binds to Site 1 and causes both repression of early transcription and 
progression in epigenetic patterns. At late times in infection the virus shifts to actively 
replicating chromosomes to be encapsulated and the transcribing late mRNA coding for 
viral proteins needed to encapsulate the chromosomes. 
 The existence and identification of 5 major epigenomes present at 48 hours post 
infection in SV40 correlates with the viral need of distinct simultaneous functions from 
the same genome. Presumably, at 48 hours these 5 epigenomes may each serve or have 
served distinct functions. For example, one could be actively replicating new 
chromosomes, another could be transcribing late mRNA to produce viral capsid proteins 
needed late in infection, while a third subset could be incorporated into newly created 
virions. The remaining epigenomes could have resulted from chromatin earlier in 
infection that are no longer needed and are now in a silenced state. Whether these 
epigenomes correspond to actual biological functions and to which function each 
epigenome would correspond to have not yet been researched. 
 
SV40 as a Model to Transmit Epigenetic Information Trans-Generationally 
 In a typical SV40 infection the virions used to initiate an infection possess 
identical epigenetic patterns as virions that result from the infection, leading to the 
question of whether virions can contain and transmit epigenetic information.  Two 
mutants, CS1085 and SM, were used to support the hypothesis that the virions could 
contain epigenetic information. If this was true, virions resulting from an infection would 
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relate to the patterns present in the minichromosomes. Both of these examined mutants 
contained distinct epigenetic patterns at both 48 hours post infection and in virion 
particles, showing that SV40 virions can contain epigenetic information and can preserve 
the epigenetic information in virion partials from infection to infection from a given set 
of environmental conditions.  
 
SV40 as a Model for Host Fever Defense 
The ability of SV40 to pass on epigenetic information in virion particles is further 
displayed when the cellular conditions in which the virus produces progeny virions have 
an elevated temperature. This is consistent with previous knowledge that fever can cause 
a heat response resulting in the change of expression and/or function of many proteins. 
(85) The virions resulting from these infections contain different epigenetic information 
and have reduced capacity to establish the next round of infection.  This body of research 
displayed this by characterizing an epi-mutant which was created from culturing SV40 
infected cells at 39°C instead of 37°C when creating virion particles.  These epi-mutant 
virions with distinct epigenetic patterns could represent one of the host’s innate immune 
defense mechanisms by epigenetically attenuating progeny virions through a fever 






SV40 as a Model for the Human Papillomavirus Family 
The human papillomaviruses (HPVs) are thought to be the agent responsible for 
many types of cervical, anogenital, head and neck cancers. This family of viruses has 
lifecycles very similar to SV40 with one important difference; the lifecycle of HPV is 
dependent on the differentiation status on the infected cells, making HPV a difficult 
candidate for use as a model system. Due to this limitation inadequate research into 
epigenetic factors relating to HPV’s lytic lifecycle has been completed. (30) It is this 
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